<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article article-type="research-article"><?OLF?><?properties olf?><front><journal-meta><journal-id journal-id-type="nlm-ta">EMBO J</journal-id><journal-title>The EMBO Journal</journal-title><issn pub-type="ppub">0261-4189</issn><issn pub-type="epub">1460-2075</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pii">emboj200847</article-id><article-id pub-id-type="doi">10.1038/emboj.2008.47</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Structural insight into the TFIIE&#x02013;TFIIH interaction: TFIIE and p53 share the binding region on TFIIH</article-title><alt-title alt-title-type="short">Mechanism of human TFIIE&#x02013;TFIIH interaction</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Okuda</surname><given-names>Masahiko</given-names></name><xref ref-type="aff" rid="O1">1</xref><xref ref-type="aff" rid="O2">2</xref><xref ref-type="author-notes" rid="n1">*</xref></contrib><contrib contrib-type="author"><name><surname>Tanaka</surname><given-names>Aki</given-names></name><xref ref-type="aff" rid="O3">3</xref><xref ref-type="author-notes" rid="n1">*</xref></contrib><contrib contrib-type="author"><name><surname>Satoh</surname><given-names>Manami</given-names></name><xref ref-type="aff" rid="O1">1</xref><xref ref-type="author-notes" rid="n2">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Mizuta</surname><given-names>Shoko</given-names></name><xref ref-type="aff" rid="O3">3</xref></contrib><contrib contrib-type="author"><name><surname>Takazawa</surname><given-names>Manabu</given-names></name><xref ref-type="aff" rid="O3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ohkuma</surname><given-names>Yoshiaki</given-names></name><xref ref-type="aff" rid="O3">3</xref></contrib><contrib contrib-type="author"><name><surname>Nishimura</surname><given-names>Yoshifumi</given-names></name><xref ref-type="aff" rid="O1">1</xref><xref ref-type="corresp" rid="c1">a</xref></contrib><aff id="O1"><label>1</label>Laboratory of Structural Biology, Graduate School of Supramolecular Biology, Yokohama City University, Yokohama, Japan</aff><aff id="O2"><label>2</label>Kihara Memorial Yokohama Foundation for the Advancement of Life Sciences, Yokohama, Japan</aff><aff id="O3"><label>3</label>Laboratory of Gene Regulation, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan</aff></contrib-group><author-notes><corresp id="c1"><label>a</label>Laboratory of Structural Biology, Graduate School of Supramolecular Biology, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan. Tel.: +81 45 508 7216; Fax: +81 45 508 7362; E-mail: <email>nisimura@tsurumi.yokohama-cu.ac.jp</email></corresp><fn id="n1"><label>*</label><p>These authors contributed equally to this work</p></fn><fn id="n2"><label>&#x02020;</label><p>Present address: RIKEN Genomic Sciences Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan</p></fn></author-notes><pub-date pub-type="epub"><day>20</day><month>03</month><year>2008</year></pub-date><fpage/><lpage/><history><date date-type="received"><day>21</day><month>11</month><year>2007</year></date><date date-type="accepted"><day>21</day><month>02</month><year>2008</year></date></history><copyright-statement>Copyright &#x000a9; 2008, European Molecular Biology Organization</copyright-statement><copyright-year>2008</copyright-year><permissions><license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc-nd/2.5/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission.</p><!--author-paid--></license></permissions><abstract><p>RNA polymerase II and general transcription factors (GTFs) assemble on a promoter to form a transcription preinitiation complex (PIC). Among the GTFs, TFIIE recruits TFIIH to complete the PIC formation and regulates enzymatic activities of TFIIH. However, the mode of binding between TFIIE and TFIIH is poorly understood. Here, we demonstrate the specific binding of the C-terminal acidic domain (AC-D) of the human TFIIE&#x003b1; subunit to the pleckstrin homology domain (PH-D) of the human TFIIH p62 subunit and describe the solution structures of the free and PH-D-bound forms of AC-D. Although the flexible N-terminal acidic tail from AC-D wraps around PH-D, the core domain of AC-D also interacts with PH-D. AC-D employs an entirely novel binding mode, which differs from the amphipathic helix method used by many transcriptional activators. So the binding surface between PH-D and AC-D is much broader than the specific binding surface between PH-D and the p53 acidic fragments. From our <italic>in vitro</italic> studies, we demonstrate that this interaction could be a switch to replace p53 with TFIIE on TFIIH in transcription.</p></abstract><kwd-group><kwd>complex structure</kwd><kwd>NMR</kwd><kwd>p53</kwd><kwd>TFIIE</kwd><kwd>TFIIH</kwd></kwd-group></article-meta></front><body><sec disp-level="1"><title>Introduction</title><p>In eukaryotes, transcription of protein-encoding genes is performed by RNA polymerase II (Pol II). Although it is a complex enzyme comprised of 12 subunits, Pol II alone is unable to accurately recognize promoters to initiate transcription. Transcription initiation by Pol II requires five proteins; TFIIB, TFIID, TFIIE, TFIIF and TFIIH collectively known as &#x02018;general transcription factors (GTFs)' (<xref ref-type="bibr" rid="b38">Orphanides <italic>et al</italic>, 1996</xref>; <xref ref-type="bibr" rid="b42">Roeder, 1996</xref>). Pol II and GTFs converge on a promoter in a highly ordered manner to form the preinitiation complex (PIC). After the binding of TFIID to the TATA element located 30 nt upstream of the transcription initiation site (&#x0002b;1), TFIIB and TFIIF together with Pol II are recruited. TFIIE then joins the PIC, and finally TFIIE recruits TFIIH. After these steps, double-stranded DNA around the initiation site is melted to the single-stranded form by TFIIH (<xref ref-type="bibr" rid="b14">Dvir <italic>et al</italic>, 1996</xref>). TFIIE binds to the region between &#x02212;10 and &#x0002b;2 (<xref ref-type="bibr" rid="b12">Douziech <italic>et al</italic>, 2000</xref>), where it is required to initiate melting and assist in the formation of the open complex (<xref ref-type="bibr" rid="b18">Holstege <italic>et al</italic>, 1996</xref>; <xref ref-type="bibr" rid="b35">Okamoto <italic>et al</italic>, 1998</xref>). Following extensive phosphorylation of the C-terminal domain (CTD) of the largest subunit Rpb1 of Pol II by TFIIH, activated Pol II releases all GTFs except for TFIIF and proceeds to transcription elongation (<xref ref-type="bibr" rid="b28">Lu <italic>et al</italic>, 1992</xref>). Upon promoter clearance, TFIIE increases the CTD kinase activity of TFIIH (<xref ref-type="bibr" rid="b13">Drapkin <italic>et al</italic>, 1994</xref>; <xref ref-type="bibr" rid="b32">Ohkuma and Roeder, 1994</xref>). Thus, it is now known that both TFIIE and TFIIH have significant functions in transcription initiation and the transition to elongation.</p><p>In relation to transcriptional machinery, so far the structures of TBP (TATA box-binding protein) subunit (<xref ref-type="bibr" rid="b30">Nikolov <italic>et al</italic>, 1992</xref>) from TFIID, TBP&#x02013;DNA (<xref ref-type="bibr" rid="b23">Kim <italic>et al</italic>, 1993a</xref>, <xref ref-type="bibr" rid="b24">1993b</xref>), TBP&#x02013;DNA&#x02013;TFIIB (<xref ref-type="bibr" rid="b29">Nikolov <italic>et al</italic>, 1995</xref>), Pol II (<xref ref-type="bibr" rid="b6">Cramer <italic>et al</italic>, 2000</xref>, <xref ref-type="bibr" rid="b7">2001</xref>) and Pol II&#x02013;TFIIB (<xref ref-type="bibr" rid="b4">Bushnell <italic>et al</italic>, 2004</xref>) have been determined. On the basis of these studies, we can see the detailed structural model for the TBP&#x02013;DNA&#x02013;TFIIB&#x02013;Pol II complex. However, for TFIIF-, TFIIE- and TFIIH-associated complex, only their several domain structures have been determined and their interaction mode has not yet been available. For the structural modelling of the PIC, many structural insights into the interactions among Pol II and GTFs, in particular the interactions between the late entries, TFIIE and TFIIIH, are required.</p><p>Human TFIIE (hTFIIE) is a heterodimer, consisting of an &#x003b1; subunit (hTFIIE&#x003b1;, 57 kDa) and a &#x003b2; subunit (hTFIIE&#x003b2;, 34 kDa) (<xref ref-type="bibr" rid="b34">Ohkuma <italic>et al</italic>, 1990</xref>, <xref ref-type="bibr" rid="b33">1991</xref>; <xref ref-type="bibr" rid="b40">Peterson <italic>et al</italic>, 1991</xref>; <xref ref-type="bibr" rid="b45">Sumimoto <italic>et al</italic>, 1991</xref>; <xref ref-type="bibr" rid="b19">Itoh <italic>et al</italic>, 2005</xref>; <xref ref-type="bibr" rid="b21">Jawhari <italic>et al</italic>, 2006</xref>). Both subunits possess several characteristic sequences and structural/functional domains; for example, a Ser, Thr, Asp and Glu-rich (STDE) sequence and an acidic amino-acid-rich sequence are found in the C-terminal region of hTFIIE&#x003b1;, whereas a Ser-rich sequence is found in the N-terminal region of hTFIIE&#x003b2;. Furthermore, two tertiary structures of a zinc-finger domain of hTFIIE&#x003b1; (<xref ref-type="bibr" rid="b36">Okuda <italic>et al</italic>, 2004</xref>) and a winged helix/forkhead domain of hTFIIE&#x003b2; (<xref ref-type="bibr" rid="b37">Okuda <italic>et al</italic>, 2000</xref>) have been solved by NMR spectroscopy.</p><p>Human TFIIH (hTFIIH) is a much larger molecule (480 kDa) consisting of 10 subunits (<xref ref-type="bibr" rid="b17">Giglia-Mari <italic>et al</italic>, 2004</xref>). This is divided into two subcomplexes, a core complex (XPB, p34, p44, p52, p62 and p8/TTDA subunits) and a CDK-activating kinase complex (CAK) (CDK7, cyclin H and MAT1 subunits). The two subcomplexes are linked by the XPD subunit (<xref ref-type="bibr" rid="b43">Schultz <italic>et al</italic>, 2000</xref>). The intriguing feature is that this factor has three enzymatic activities: ATP-dependent DNA helicase, DNA-dependent ATPase and CTD kinase activities, and participates not only in transcription but also in DNA repair and cell cycle control. Of these activities of hTFIIH, hTFIIE stimulates the CTD kinase and ATPase activities, and represses the helicase activity (<xref ref-type="bibr" rid="b28">Lu <italic>et al</italic>, 1992</xref>; <xref ref-type="bibr" rid="b13">Drapkin <italic>et al</italic>, 1994</xref>; <xref ref-type="bibr" rid="b32">Ohkuma and Roeder, 1994</xref>).</p><p>With regard to the interaction between hTFIIE and hTFIIH, it has been shown that the C-terminal acidic region of hTFIIE&#x003b1; is necessary for native hTFIIH binding (<xref ref-type="bibr" rid="b31">Ohkuma <italic>et al</italic>, 1995</xref>) and hTFIIE&#x003b1; strongly binds to the p62 subunit of hTFIIH (<xref ref-type="bibr" rid="b49">Yamamoto <italic>et al</italic>, 2001</xref>; <xref ref-type="bibr" rid="b36">Okuda <italic>et al</italic>, 2004</xref>). Besides these findings, however, little was known about this fundamental mechanism. Insight into the mechanism is gained from the work described here, which demonstrates that the C-terminal acidic domain (AC-D) of hTFIIE&#x003b1; containing the acidic region specifically binds to the N-terminal pleckstrin homology domain (PH-D) of the p62 subunit of hTFIIH. We have determined structures of both free hTFIIE&#x003b1; AC-D and its form bound to the PH-D of hTFIIH p62 by using NMR spectroscopy. The structures reveal that hTFIIE&#x003b1; AC-D recognizes p62 PH-D tightly through a combination of hydrophobic and electrostatic interactions. hTFIIE&#x003b1; AC-D is found to share its binding surface on p62 PH-D with the acidic transactivation domains (TADs) of tumour supressor protein p53 (<xref ref-type="bibr" rid="b8">Di Lello <italic>et al</italic>, 2006</xref>) and herpes simplex virus protein VP16 (<xref ref-type="bibr" rid="b10">Di Lello <italic>et al</italic>, 2005</xref>). However, hTFIIE&#x003b1; AC-D employs an entirely novel binding mode, which differs from the amphipathic helix method used by many transcriptional activators. Our structural and functional studies are informative with regard to the roles of these proteins in the transcription initiation mechanism.</p></sec><sec disp-level="1"><title>Results</title><sec disp-level="2"><title>Structure of hTFIIE<italic>&#x003b1;</italic> AC-D</title><p>It has been reported that the C-terminal acidic region of hTFIIE&#x003b1; is necessary for hTFIIH binding (<xref ref-type="fig" rid="f1">Figure 1A</xref>) (<xref ref-type="bibr" rid="b31">Ohkuma <italic>et al</italic>, 1995</xref>). To characterize the precise interaction at the molecular level, we first solved a solution structure of the AC-D of hTFIIE&#x003b1; using NMR spectroscopy (<xref ref-type="fig" rid="f1">Figure 1B</xref> and <xref ref-type="table" rid="t1">Table I</xref>). The protein has a globular structure with flexible and disordered tails, consisting of the 16 N-terminal residues (amino acids 378&#x02013;393) and the 5 C-terminal residues (amino acids 435&#x02013;439). The core region forms a compact structure; the &#x003b2;-turn (S1&#x02013;S2) is followed by three &#x003b1;-helices (H1, H2 and H3). These structural elements interact with each other and are maintained by a small but rigid hydrophobic core formed by P394, V396, V398, F403, Y405, V408, L414, V415, M418, E422, K423, Y426, I427, M429 and M433 residues. As the hydrophobic core residues as well as consecutive acidic amino acids found in the N-terminal regions of the AC-Ds are highly conserved in metazoans, they would all be expected to have similar structural features to hTFIIE&#x003b1; AC-D (<xref ref-type="fig" rid="f1">Figure 1A</xref>). The structure seems to be a novel fold; similar structures with a <italic>Z</italic> score over 2.0 could not be detected by the DALI server.</p></sec><sec disp-level="2"><title>hTFIIE<italic>&#x003b1;</italic> AC-D specifically binds to PH-D of hTFIIH p62</title><p>Previous studies showed that hTFIIE&#x003b1; specifically bound to the p62 subunits of hTFIIH (<xref ref-type="bibr" rid="b49">Yamamoto <italic>et al</italic>, 2001</xref>; <xref ref-type="bibr" rid="b36">Okuda <italic>et al</italic>, 2004</xref>). Given that the C-terminal acidic region of hTFIIE&#x003b1; (residues 378&#x02013;393) is essential for hTFIIH binding (<xref ref-type="bibr" rid="b31">Ohkuma <italic>et al</italic>, 1995</xref>), hTFIIE&#x003b1; AC-D is likely to be responsible for hTFIIH recognition. To confirm this and to identify the AC-D-binding region in p62, we performed a GST pull-down assay using hTFIIE&#x003b1; AC-D and GST-fused p62 deletion mutants (<xref ref-type="fig" rid="f2">Figure 2A</xref>). After purification by glutathione-Sepharose column chromatography, all samples containing the C-terminal region, namely full-length GST&#x02013;p62<sub>1&#x02212;548</sub>, GST&#x02013;p62<sub>109&#x02212;548</sub>, GST&#x02013;p62<sub>238&#x02212;548</sub> and GST&#x02013;p62<sub>333&#x02212;548</sub>, were considerably degraded or incompletely translated (data not shown). Though such instability of the C-terminal half of p62 has previously been reported (<xref ref-type="bibr" rid="b20">Jawhari <italic>et al</italic>, 2004</xref>), we found that full-length GST&#x02013;p62<sub>1&#x02212;548</sub>, GST&#x02013;p62<sub>1&#x02212;108</sub>, GST&#x02013;p62<sub>1&#x02212;238</sub> and GST&#x02013;p62<sub>1&#x02212;333</sub> bound to hTFIIE&#x003b1; AC-D, whereas no binding was observed with GST&#x02013;p62<sub>109&#x02212;548</sub>, GST&#x02013;p62<sub>238&#x02212;548</sub>, GST&#x02013;p62<sub>333&#x02212;548</sub> and GST alone (<xref ref-type="fig" rid="f2">Figure 2B</xref>). p62 contains the structurally stable PH-D (residues 1&#x02013;108) (<xref ref-type="bibr" rid="b16">Gervais <italic>et al</italic>, 2004</xref>) and double BSD domains (residues 109&#x02013;232) (<xref ref-type="bibr" rid="b11">Doerks <italic>et al</italic>, 2002</xref>) within the N-terminal half. The truncation variants with hTFIIE&#x003b1;-binding ability all possess the PH-D. We therefore asked whether p62 PH-D could interact with full-length hTFIIE&#x003b1; (<xref ref-type="fig" rid="f2">Figure 2B</xref>). The results showed that GST-fused p62<sub>1&#x02212;548</sub>, p62<sub>1&#x02212;108</sub>, p62<sub>1&#x02212;238</sub> and p62<sub>1&#x02212;333</sub>, all of which contain N-terminal 108 residues, bound to hTFIIE&#x003b1;, whereas the mutants p62<sub>109&#x02212;548</sub>, p62<sub>238&#x02212;548</sub> and p62<sub>333&#x02212;548</sub>, which lack those 108 residues, could not bind to hTFIIE&#x003b1; (<xref ref-type="fig" rid="f2">Figure 2B</xref>, lanes 2&#x02013;5 versus lanes 6&#x02013;8). Thus, we concluded that hTFIIE&#x003b1; binds specifically to the PH-D of hTFIIH p62 (p62 PH-D) through its AC-D.</p></sec><sec disp-level="2"><title>Structure of complex between hTFIIE<italic>&#x003b1;</italic> AC-D and hTFIIH p62 PH-D</title><p>To obtain the p62 PH-D-bound structure of hTFIIE&#x003b1; AC-D using NMR, we performed NMR titration experiments in buffers both with and without 100 mM NaCl for both domains (<xref ref-type="supplementary-material" rid="S1">Supplementary Figures 1&#x02013;3</xref>). Although in the 100 mM NaCl buffer the dissociation constant (<italic>K</italic><sub>d</sub>) between AC-D and p62 PH-D was estimated from the titration plots as 376&#x000b1;81 nM (<xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1C</xref>) or 237&#x000b1;82 nM (<xref ref-type="supplementary-material" rid="S1">Supplementary Figure 2C</xref>), the NaCl-free buffer NMR titration experiment showed much stronger binding affinity between AC-D and p62 PH-D because of the slow exchange timescale with a <italic>K</italic><sub>d</sub> below about 150 nM (<xref ref-type="supplementary-material" rid="S1">Supplementary Figure 3</xref>). On the basis of these results, we determined the complex structure in 20 mM potassium phosphate buffer without NaCl.</p><p>In total, 4489 NOE-derived distance restraints, including 371 intermolecular NOEs, 120 hydrogen bond restraints and 282 dihedral angle restraints were used to determine the complex structure (<xref ref-type="table" rid="t1">Table I</xref>). The complex structure is shown in <xref ref-type="fig" rid="f3">Figure 3A and B</xref>. The occluded solvent-accessible surface between hTFIIE&#x003b1; AC-D and p62 PH-D was &#x0223c;2300 &#x000c5;<sup>2</sup>. The core structure of hTFIIE&#x003b1; AC-D and p62 PH-D in the complex was essentially the same as seen in each isolated free structure except for the extended and highly acidic N-terminal tail of hTFIIE&#x003b1; AC-D. In the free form, it is disordered (<xref ref-type="fig" rid="f1">Figure 1B</xref>) but upon complex formation becomes fixed, forming a new S0 strand that extensively overlays the positively charged surface of p62 PH-D formed by K18, K19, K54, K60, K62 and K93 (<xref ref-type="fig" rid="f3">Figure 3C</xref>). Nine consecutive acidic residues from the N-terminal tail of hTFIIE&#x003b1; AC-D run across the second &#x003b2;-sheet (S5, S6 and S7) of p62 PH-D, electrostatically interacting with K18 and K19 on the loop between the S1 and S2 strands and K60 and K62 on the loop between S5 and S6 strands. The extended tail of hTFIIE&#x003b1; AC-D curves at E386 (<xref ref-type="fig" rid="f3">Figure 3B</xref>). Polypeptides from F387 to A391 of hTFIIE&#x003b1; AC-D align along the S5 strand of p62 PH-D, forming an antiparallel &#x003b2;-sheet structure with it. It is noteworthy that F387 in the sequence of acidic residues is accommodated in a shallow pocket on the second &#x003b2;-sheet of p62 PH-D formed by K54, I55, S56, K60, Q64, L65, Q66 and N76 (<xref ref-type="fig" rid="f3">Figure 3D</xref>). In the pocket, hydrophobic interactions between the aromatic side chain of F387 (hTFIIE&#x003b1;) and the aliphatic portions of K54 and K60 (p62) and amino-aromatic interactions (<xref ref-type="bibr" rid="b2">Burley and Petsko, 1986</xref>) between the side chains of F387 and Q64, Q66 and N76 (p62) were observed. E388 (hTFIIE&#x003b1;) interacts through van der Waals contacts with I55 and P57 (p62), and E389 (hTFIIE&#x003b1;) forms a salt bridge with K54 (p62). Similar to as seen for F387 (hTFIIE&#x003b1;), V390 was inserted into a shallow pocket between the S5 strand and the C-terminal H1 helix of p62 PH-D, formed by Q53 and I55 on the S5 strand and K93 and Q97 on the H1 helix (<xref ref-type="fig" rid="f3">Figure 3E</xref>). V390 makes extensive hydrophobic contacts with I55 and the aliphatic regions of Q53, K93 and Q97. The N-terminal tail of hTFIIE&#x003b1; AC-D bends further at D392 (<xref ref-type="fig" rid="f3">Figure 3B</xref>), which causes van der Waals contacts between L100 and P101 (p62) (<xref ref-type="fig" rid="f3">Figure 3F</xref>). D393 (hTFIIE&#x003b1;) at the end of the tail lies in close proximity to Q97 (p62) making van der Waals contact with it.</p><p>These interacting amino acids were also observed in the NMR titration experiments. In hTFIIE&#x003b1; AC-D, the NMR signals of E386, F387, E388, E389, V390, A391 and D392 were changed significantly upon addition of p62 PH-D (<xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1B</xref>) and also in p62 PH-D the NMR signals of K19, Q53, K54, I55, S56, E58, K60, A61, I63, Q64, L65, Q66, T74, T75 and F77 were changed by adding hTFIIE&#x003b1; AC-D (<xref ref-type="supplementary-material" rid="S1">Supplementary Figure 2B</xref>).</p><p>It is remarkable that in addition to the interaction involving the N-terminal flexible tail of hTFIIE&#x003b1; AC-D, its core structure also participates in the binding to p62 PH-D (<xref ref-type="fig" rid="f3">Figure 3F</xref>). Several residues in the N- and C-terminal regions of the hTFIIE&#x003b1; AC-D core structure interact with residues located in the C-terminal region of p62 PH-D. P394 (hTFIIE&#x003b1;) at the N terminus of the core structure contributes to the formation of the hydrophobic core of hTFIIE&#x003b1; AC-D and simultaneously makes intimate van der Waals contacts with P101 (p62) and also with the aliphatic portion of Q98 (p62). I395 (hTFIIE&#x003b1;), which is exposed to the surface in the free form, now makes hydrophobic contact with the aliphatic segment of Q98 (p62). R432 (hTFIIE&#x003b1;), which is at the end of the H3 helix, makes van der Waals contacts with P101 and the hydrophobic portion of K102 (p62). M433 (TFIIE&#x003b1;) makes van der Waals contact with the aliphatic region of K104 (p62), which is also able to make an electrostatic interaction with D392 or D436. These interactions allow the core structure of hTFIIE&#x003b1; AC-D to take up a position to the side of p62 PH-D, such that the whole complex structure is well defined as shown in <xref ref-type="fig" rid="f3">Figure 3A</xref>.</p></sec><sec disp-level="2"><title>Effects of hTFIIE<italic>&#x003b1;</italic> AC-D mutations on binding to p62 PH-D</title><p>In functional studies of hTFIIE&#x003b1;, we made several mutants of hTFIIE&#x003b1; by changing S365, V372, D380, E383, F387, V390 and D393 to alanine (S365A, V372A, D380A, E383A, F387A, V390A and D393A) as well as S365E, V372D, F387E and V390K. These mutants were expressed in <italic>Escherichia coli</italic> with hexa-histidine (6H) at the N terminus. All were soluble and could therefore be easily purified using a Ni-nitrilotriacetic acid (NTA) agarose column (<xref ref-type="fig" rid="f4">Figure 4A</xref>).</p><p>The ability of hTFIIE&#x003b1; mutants to bind to GST-tagged p62 PH-D was examined by <italic>in vitro</italic> binding assay (<xref ref-type="fig" rid="f4">Figure 4B</xref>). The p62 PH-D-binding activity of the hTFIIE&#x003b1; mutants was severely reduced when the AC-D residues, F387 and V390, which fit into shallow pockets of p62 PH-D, were changed to F387A, F387E, V390A and V390K (<xref ref-type="fig" rid="f4">Figure 4B</xref>, second column p62 PH-D, lanes 9&#x02013;12). We have shown previously that the N terminus of hTFIIE&#x003b1; is essential for binding to hTFIIE&#x003b2; (<xref ref-type="bibr" rid="b31">Ohkuma <italic>et al</italic>, 1995</xref>). Consistent with these observations is the fact that none of the hTFIIE&#x003b1; mutations affected the binding of hTFIIE&#x003b1; to hTFIIE&#x003b2; (<xref ref-type="fig" rid="f4">Figure 4B</xref>, third column IIE&#x003b2;, lanes 3&#x02013;13).</p></sec><sec disp-level="2"><title>Functional roles of hTFIIE<italic>&#x003b1;</italic> AC-D during transcription</title><p>To further investigate the functional roles of hTFIIE&#x003b1; AC-D, we first checked the effects of the hTFIIE&#x003b1; mutants on basal transcription using the adenovirus major late pML(C<sub>2</sub>AT)&#x00394;-50 template (<xref ref-type="fig" rid="f4">Figure 4C</xref>). All mutants exhibited defects in transcription. Intriguingly, however, the mutants of S365A, S365E, V372A, V372D, D380A and E383A showed more defects than the p62 PH-D-binding defective mutants (<xref ref-type="fig" rid="f4">Figure 4C</xref>, lanes 3&#x02013;8 versus lanes 9&#x02013;13).</p><p>We next tested the effects on CTD phosphorylation. Each hTFIIE&#x003b1; mutant was mixed with hTFIIH and Pol II. The mixture was analysed by SDS&#x02013;PAGE and phosphorylated Rpb1 from Pol II was detected by autoradiography (<xref ref-type="fig" rid="f4">Figure 4D</xref>). All mutants failed to stimulate CTD phosphorylation properly compared with wild type (<xref ref-type="fig" rid="f4">Figure 4D</xref>, lanes 3&#x02013;13 versus lane 2). Phosphorylation profiles of the above-described mutants (S365A, S365E, V372A, V372D, D380A and E383A) phosphorylated CTD but most of Rpb1 was detected at the hypo-phosphorylated IIa position (<xref ref-type="fig" rid="f4">Figure 4D</xref>, lanes 3&#x02013;8). In contrast, the p62 PH-D-binding defective mutants phosphorylated CTD only weakly (<xref ref-type="fig" rid="f4">Figure 4D</xref>, lanes 9&#x02013;12).</p></sec><sec disp-level="2"><title>A part of the hTFIIE-binding surface on hTFIIH p62 is shared with transcriptional activator p53</title><p>Recently, the structure of a complex of the PH-D of <italic>Saccharomyces cerevisiae</italic> Tfb1, a homologue of human p62, with a TAD2 of activator p53 was determined by NMR spectroscopy (<xref ref-type="bibr" rid="b8">Di Lello <italic>et al</italic>, 2006</xref>). The structure of the Tfb1 PH-D closely resembles that of p62, except for its longer connecting loop between S6 and S7 (<xref ref-type="fig" rid="f5">Figure 5A and B</xref>). Furthermore, the herpes simplex virus protein 16 (VP16) TAD also interacts with virtually identical sites of Tfb1 and p62 PH-D (<xref ref-type="bibr" rid="b10">Di Lello <italic>et al</italic>, 2005</xref>). Interestingly, the binding sites of p62 for p53 TAD2 and VP16 TAD significantly overlap with a part of the binding site for hTFIIE&#x003b1; AC-D. However, their binding mode is entirely different. The binding site of p53 TAD2 peptide is disordered in an unbound state, but it forms a nine-residue amphipathic &#x003b1;-helix upon binding to Tfb1 PH-D and p62 PH-D. The p53 helix contacts the second &#x003b2;-sheet of Tfb1 PH-D through the interactions of I50 (p53)&#x02014;M59, M88 (Tfb1); E51 (p53)&#x02014;R61 or R86 (Tfb1); W53 (p53)&#x02014;K57, M59 (Tfb1); F54 (p53)&#x02014;Q49, A50, T51, M59, L60, R61 (Tfb1); and E56 (p53)&#x02014;K57 (Tfb1). Although the N-terminal tail of hTFIIE&#x003b1; AC-D also becomes ordered upon binding to p62 PH-D, it forms a bent extended structure containing a S0 strand, but not &#x003b1;-helix. In spite of such great structural differences, both hTFIIE&#x003b1; AC-D and p53 TAD2 peptide insert phenylalanine residues, F387 of hTFIIE&#x003b1; AC-D and F54 of p53 TAD2, into the equivalent pocket on the second &#x003b2;-sheet of p62 PH-D. Although the p53 TAD2 peptide consisting of residues 20&#x02013;73 forms no contacts beside this limited area, hTFIIE&#x003b1; AC-D further interacts with p62 PH-D as mentioned above. The binding surface area of hTFIIE&#x003b1; AC-D and p62 PH-D is calculated as &#x0223c;2300 &#x000c5;<sup>2</sup>, which is much larger than the binding area of p53 TAD2 for Tfb1 calculated as &#x0223c;800 &#x000c5;<sup>2</sup>.</p><p>To analyse this interaction biochemically, several point mutants of p62 PH-D were created, bacterially expressed and used in binding studies with hTFIIE&#x003b1; AC-D and p53<sub>1&#x02212;73</sub> (<xref ref-type="fig" rid="f5">Figure 5C</xref>). As controls, AC-D-containing hTFIIE&#x003b1; wild type (IIE&#x003b1; wt) and hTFIIE&#x003b1;<sub>351&#x02212;439</sub> (IIE&#x003b1;<sub>351&#x02212;439</sub>) were also examined in parallel. As shown, K54, which forms the shallow pocket for F387 of hTFIIE&#x003b1; AC-D with its side chain interacting electrostatically with E389 of hTFIIE&#x003b1; AC-D, was the residue for which mutation to alanine had the largest effect as it prevented binding of all three hTFIIE&#x003b1; proteins tested (<xref ref-type="fig" rid="f5">Figure 5C</xref>, lane 5). In addition, Q66, which also forms the same shallow pocket for F387 of hTFIIE&#x003b1; AC-D and the side chain of Q66 makes contact with F387 through amino-aromatic interaction, was shown to be essential for binding to hTFIIE&#x003b1; AC-D (<xref ref-type="fig" rid="f5">Figure 5C</xref>, lane 6). The adjacent residues, V68, T74 and N76 of p62 PH-D as well as the N-terminal basic residues, K18 and K19, also affected binding but to a lesser extent (<xref ref-type="fig" rid="f5">Figure 5C</xref>, lanes 3, 4, 7&#x02013;9). A similar but distinct inhibition profile was observed for the N-terminal TAD of p53 (p53<sub>1&#x02212;73</sub>). In this case, Q66 was also central to the interaction but the essential binding residues were more widespread (<xref ref-type="fig" rid="f5">Figure 5C</xref>, the bottom column, lanes 3 and 6&#x02013;9).</p></sec><sec disp-level="2"><title>Replacement of p53 bound to hTFIIH p62 with hTFIIE<italic>&#x003b1;</italic></title><p>As the overlap of the p62 PH-D-binding region of hTFIIE&#x003b1; AC-D with that of p53 TAD2 was observed and judging from the functional context that p53 may recruit TFIIH at transcriptional activation but at some point TFIIE should take over to recruit TFIIH into the PIC, we then asked whether p53 can be replaced on p62 with hTFIIE&#x003b1;. As shown in <xref ref-type="fig" rid="f5">Figure 5D</xref>, p62 PH-D bound to GST&#x02013;p53 TAD (p53<sub>1&#x02212;73</sub>) was removed upon addition of 6H&#x02013;hTFIIE&#x003b1; wild type (<xref ref-type="fig" rid="f5">Figure 5D</xref>, lanes 2&#x02013;4). Unbound fractions were then mixed with Ni-NTA resin and FLAG-p62 PH-D bound to 6H&#x02013;hTFIIE&#x003b1; was detected by western blotting (<xref ref-type="fig" rid="f5">Figure 5D</xref>, lanes 7&#x02013;9). This clearly demonstrates that p53 binding to p62 can be replaced with hTFIIE&#x003b1;.</p></sec></sec><sec disp-level="1"><title>Discussion</title><sec disp-level="2"><title>Interaction between hTFIIE<italic>&#x003b1;</italic> AC-D and hTFIIH p62 PH-D and its evolutionary conservation</title><p>In the present study, the specific interaction between hTFIIE&#x003b1; AC-D and hTFIIH p62 PH-D was explored, and structures of both the free and PH-D-bound forms of hTFIIE&#x003b1; AC-D were determined. This is the first report of the structural determination of the complex describing the interaction between TFIIE and TFIIH at the molecular level. In the case of hTFIIE&#x003b1; AC-D, its binding site as identified here (residues 378&#x02013;395) is consistent with the previous report that a deletion mutant of hTFIIE&#x003b1;, &#x00394;377&#x02013;393 could no longer bind to hTFIIH, whereas a mutant with residues 351&#x02013;439 could bind (<xref ref-type="bibr" rid="b31">Ohkuma <italic>et al</italic>, 1995</xref>). hTFIIE&#x003b1; possesses another acidic region, the STDE (Ser, Thr, Asp and Glu-rich) region (residues 352&#x02013;365) immediately before the hTFIIE&#x003b1; AC-D (<xref ref-type="fig" rid="f1">Figure 1A</xref>). To investigate whether the STDE is involved in the binding, we prepared a longer construct (residues 351&#x02013;439) containing both acidic regions and performed the NMR titration experiment under the same conditions (<xref ref-type="supplementary-material" rid="S1">Supplementary Figure 4</xref>). The result was that the NMR signals of STDE showed no significant changes and the <italic>K</italic><sub>d</sub> of 400&#x000b1;43 nM was almost the same as that estimated using hTFIIE&#x003b1; AC-D. We also examined the binding ability of peptide possessing only an N-terminal tail (AC-D<sub>381&#x02212;394</sub>) (<xref ref-type="supplementary-material" rid="S1">Supplementary Figure 5</xref>). hTFIIE&#x003b1; AC-D<sub>381&#x02212;394</sub> bound to p62 PH-D with a <italic>K</italic><sub>d</sub> of 2123&#x000b1;192 nM, which is about &#x0223c;6- to 9-fold weaker than that of hTFIIE&#x003b1; AC-D. Although the residues of p62 PH-D whose signals changed significantly were mostly consistent with the binding of AC-D and AC-D<sub>381&#x02212;394</sub>, the extents of signal changes in the C-terminal region, to which I395, R432 and M433 of AC-D bind, were reduced. These results clearly indicate that hTFIIE&#x003b1; AC-D, which contains both the core structure and the flexible tail, is necessary and sufficient for the specific binding. This is an entirely new binding mode compared with the canonical binding modes found in some transcriptional activators or repressors, in which an intrinsically disordered region (<xref ref-type="bibr" rid="b15">Dyson and Wright, 2002</xref>) of each activation or repression domain binds to a target protein with part of the flexible region forming an ordered structure upon binding to the target. The core structure of hTFIIE&#x003b1; AC-D is essential for its binding to p62 PH-D in addition to its flexible arm.</p><p>The binding site of hTFIIH p62 PH-D was localized to the second &#x003b2;-sheet (S5, S6 and S7), the loops between S1 and S2 and between S5 and S6 and the C-terminal H1 helix, where a substantial positive cluster is formed. Therefore, it is reasonable to speculate that the N-terminal highly acidic tail of hTFIIE&#x003b1; AC-D strongly binds to the positively charged surface of hTFIIH p62 PH-D. This is supported by the result that the binding is strengthened by removing NaCl from the buffer in the NMR titration experiments. However, given that the first acidic region, STDE, of hTFIIE&#x003b1; has no effect on the binding, the interaction is not merely based on electrostatic interactions. As seen in the complex structure, the highly conserved F387 and V390 residues in the acidic region of hTFIIE&#x003b1; AC-D, not in the STDE region (<xref ref-type="fig" rid="f1">Figure 1A</xref>) make a large contribution to binding. Thus, the combination of electrostatic and hydrophobic interactions is essential for specific binding.</p><p>It is interesting that hTFIIE&#x003b1; AC-D partially shares the binding surface of hTFIIH p62 PH-D with acidic transcriptional activators, p53 and VP16 TADs (<xref ref-type="bibr" rid="b10">Di Lello <italic>et al</italic>, 2005</xref>, <xref ref-type="bibr" rid="b8">2006</xref>). As p53 and VP16 TADs are able to bind to the PH-Ds of both p62 and Tfb1, their interactions are likely to be evolutionally conserved. For yeast TFIIE&#x003b1; (Tfa1), functional significance of the C-terminal region and specific interaction between Tfa1 and Tfb1 has been reported (<xref ref-type="bibr" rid="b3">Bushnell <italic>et al</italic>, 1996</xref>; <xref ref-type="bibr" rid="b25">Kuldell and Buratowski, 1997</xref>). We aligned sequences of TFIIE&#x003b1; AC-D from other species to ascertain whether the interaction observed in human is evolutionally conserved (<xref ref-type="fig" rid="f1">Figure 1A</xref>). As described above, the residues forming the hydrophobic core are well conserved in metazoans, but not in yeast, <italic>S. cerevisiae</italic> and <italic>Schizosaccharomyces pombe</italic>. Thus, yeast homologues are unlikely to have a similar core structure to that of human AC-D. However, in yeast similar sequences to the binding site are found in the equivalent positions. Furthermore, in contrast to metazoans, only fungal homologues possess the third acidic region at the C termini. Surprisingly, similar sequences to the binding site are found in the third acidic regions of both <italic>S. cerevisiae</italic> and <italic>S. pombe</italic>. Considering that the main binding site of hTFIIE&#x003b1; AC-D is located on the N-terminal tail outside the core structure, Tfa1 does not seem to have a similar core AC-D structure, but the interaction with PH-D is likely to be conserved. This suggests that the interplay between hTFIIE&#x003b1; AC-D, hTFIIH p62 PH-D and p53 TAD2 (and VP16 TAD as well) is evolutionally conserved.</p></sec><sec disp-level="2"><title>Functional roles of hTFIIE<italic>&#x003b1;</italic> AC-D</title><p>In hTFIIE&#x003b1; AC-D, F387 and V390 are the centre of the p62 PH-D-binding region (<xref ref-type="fig" rid="f4">Figure 4B</xref>). As expected, the p62 PH-D-binding defective mutants (F387A, F387E, V390A and V390K) showed defects in <italic>in vitro</italic> transcription (20&#x02013;40&#x00025; reduction from the wild type, <xref ref-type="fig" rid="f4">Figure 4C</xref>, lane 2 versus lanes 9&#x02013;12). The reason why transcription did not correlate well with the binding and CTD phosphorylation defects might be because there are more than 25 proteins involved in transcription, whereas only limited factors were used for both binding and phosphorylation studies (hTFIIE&#x003b1; AC-D mutants and p62 PH-D were used for binding studies and hTFIIE&#x003b1; AC-D mutants, hTFIIH and Pol II were used for CTD phosphorylation). As a result, other GTFs will be able to support the recruitment of hTFIIH to the correct position in the PIC even in the absence of hTFIIE&#x003b1; AC-D. In addition, bigger defects were observed for mutations of the STDE and in the N-terminal half of hTFIIE&#x003b1; AC-D (S365, V372, D380 and E383) (<xref ref-type="fig" rid="f4">Figure 4C</xref>, lanes 3&#x02013;8). This effect maybe a result of the action of GTFs with the possibility that this region of hTFIIE&#x003b1; exerts an effect as a binding site for one or more of the general factors. We will test this possibility in the immediate future.</p></sec><sec disp-level="2"><title>Functional implication of the interplay between TFIIE, TFIIH and acidic transcriptional activators</title><p>In many cases, acidic TADs are disordered in an unbound form, but form an amphipathic helix upon binding to target proteins, for example, p53 TAD2&#x02013;RPA70 (replication protein A 70) (<xref ref-type="bibr" rid="b1">Bochkareva <italic>et al</italic>, 2005</xref>), p53 TAD1&#x02013;MDM2 (ubiquitin ligase) (<xref ref-type="bibr" rid="b27">Kussie <italic>et al</italic>, 1996</xref>), VP16 TAD&#x02013;hTAF<sub>II</sub>31 (human TBP-associated factor) (<xref ref-type="bibr" rid="b46">Uesugi <italic>et al</italic>, 1997</xref>) complexes as well as the recently determined Tfb1 PH-D&#x02013;p53 TAD2 complex (<xref ref-type="bibr" rid="b8">Di Lello <italic>et al</italic>, 2006</xref>). In contrast, hTFIIE&#x003b1; AC-D uniquely binds to p62 PH-D through its core structure together with its flexible N-terminal tail. The <italic>K</italic><sub>d</sub> values for the binding of p53 TAD2 to p62 and Tfb1 PH-Ds determined by isothermal titration calorimetry (ITC) are 3175&#x000b1;570 and 391&#x000b1;74 nM, respectively (<xref ref-type="bibr" rid="b8">Di Lello <italic>et al</italic>, 2006</xref>). In the binding of VP16 TAD to Tfb1 PH-D, the <italic>K</italic><sub>d</sub> value estimated by NMR titration experiment was &#x0223c;4000&#x02013;7000 nM (<xref ref-type="bibr" rid="b10">Di Lello <italic>et al</italic>, 2005</xref>). Compared with these <italic>K</italic><sub>d</sub> values, the binding of hTFIIE&#x003b1; AC-D to p62 PH-D is rather strong. One of the well-known functions of transcriptional activators is to promote transcription initiation by increasing recruitment efficiency of Pol II and GTFs (<xref ref-type="bibr" rid="b41">Ptashne and Gann, 1997</xref>). TFIIH is recruited through many activator-mediated routes. p62 has been shown to interact with the TADs of not only VP16 and p53 (<xref ref-type="bibr" rid="b48">Xiao <italic>et al</italic>, 1994</xref>) but also E2F-1 (<xref ref-type="bibr" rid="b39">Pearson and Greenblatt, 1997</xref>), and the oestrogen receptor &#x003b1; (ER&#x003b1;) (<xref ref-type="bibr" rid="b5">Chen <italic>et al</italic>, 2000</xref>). Of these, it was demonstrated that p53, VP16 and ER&#x003b1; target p62 PH-D. The notable finding from the present study is that hTFIIE&#x003b1; also targets p62 PH-D (<xref ref-type="fig" rid="f2">Figure 2</xref>). To our knowledge, this is the first GTF demonstrated to possess a functional TAD-like motif. As shown in <xref ref-type="fig" rid="f5">Figure 5D</xref>, hTFIIE&#x003b1; could replace p53 TAD and then bind to p62 PH-D. It can be imagined that if TFIIH is recruited by an activator near the promoter through its TAD then the recruited TFIIH could be captured by TFIIE instead of the activator to form the PIC. TFIIE regulates the enzymatic activities of TFIIH, which are necessary for the next stage after the PIC formation, that is, promoter melting or promoter clearance. In contrast, activators cannot directly participate in these processes. Efficient delivery of p62 from activators to TFIIE&#x003b1; is considered to be essential for the final recruitment of TFIIH to form the PIC <italic>in vivo</italic>. The replacement observed in <xref ref-type="fig" rid="f5">Figure 5D</xref> could be related to this final recruitment. We show in <xref ref-type="fig" rid="f5">Figure 5A&#x02013;C</xref> that p53 (<xref ref-type="bibr" rid="b8">Di Lello <italic>et al</italic>, 2006</xref>) and VP16 (<xref ref-type="bibr" rid="b10">Di Lello <italic>et al</italic>, 2005</xref>) use part of the binding surface formed between p62 PH-D and hTFIIE&#x003b1; AC-D. The use of an overlapping binding surface on p62 PH-D with p53 TAD2 may be advantageous in the delivery of TFIIH from activators to TFIIE.</p><p>The binding affinity of p53 TAD2 to p62 PH-D is regulated by S46 and T55 phosphorylation (<xref ref-type="bibr" rid="b8">Di Lello <italic>et al</italic>, 2006</xref>). The <italic>K</italic><sub>d</sub> values of p53 TAD2 to p62 PH-D are reported for the unphosphorylated form as 3175&#x000b1;570 nM, for the S46-phosphorylated form as 518&#x000b1;92 nM, for the T55-phosphorylated form as 457&#x000b1;75 nM and for both S46- and T55-phosphorylated form as 97&#x000b1;33 nM. Very recent ITC studies demonstrated the <italic>K</italic><sub>d</sub> value of hTFIIE&#x003b1;<sub>336&#x02212;439</sub> to p62 PH-D to be 45&#x000b1;25 nM (<xref ref-type="bibr" rid="b9">Di Lello <italic>et al</italic>, 2008</xref>). Intriguingly, the binding affinity of hTFIIE&#x003b1;<sub>336&#x02212;439</sub> to p62 PH-D is much stronger than unphosphorylated p53 TAD2 and is comparable to doubly phosphorylated TAD2. As both TFIIH and p53 function not only in transcription but also in DNA repair (<xref ref-type="bibr" rid="b22">Kastan <italic>et al</italic>, 1991</xref>; <xref ref-type="bibr" rid="b13">Drapkin <italic>et al</italic>, 1994</xref>) and p62 PH-D is involved in nucleotide excision repair (<xref ref-type="bibr" rid="b16">Gervais <italic>et al</italic>, 2004</xref>), p62 may serve as a molecular switch between transcription and DNA repair. We imagine that when p53 TAD2 is unphosphorylated, the delivery of p62 from p53 TAD2 to hTFIIE&#x003b1; would be efficient and they would function cooperatively in transcription initiation. However, when p53 TAD2 is doubly phosphorylated at S46 and T55, the affinity of p53 TAD2 for p62 PH-D would be comparable to that for hTFIIE&#x003b1; resulting in p53 and p62 (hTFIIH) functioning in DNA repair or in processes other than transactivation. Further studies are required to verify these possibilities.</p></sec></sec><sec disp-level="1" sec-type="materials|methods"><title>Materials and methods</title><sec disp-level="2"><title>Construction of mutants of hTFIIE<italic>&#x003b1;</italic> and hTFIIH p62 subunits</title><p>By using the Multi Site-Directed Mutagenesis Kit (Medical Biology Laboratory) as a template with wild-type hTFIIE&#x003b1; cDNA plasmid or a hTFIIH p62 cDNA mutant in which a <italic>Nde</italic>I site was disrupted by changing the third nucleotide of the 45th histidine codon of wild-type hTFIIH p62 cDNA, T to C, various oligonucleotide-mediated point mutants were created (<xref ref-type="bibr" rid="b26">Kunkel <italic>et al</italic>, 1987</xref>). The mutants were checked by sequencing using an ABI Prism 310 Genetic Analyzer (Applied Biosystems). The oligonucleotides used for mutation are listed in <xref ref-type="supplementary-material" rid="S1">Supplementary Table I</xref>. The <italic>Nde</italic>I&#x02013;<italic>Bam</italic>HI fragment of mutated hTFIIE&#x003b1; cDNA was subcloned into the pET11d vector (Novagen) making the N-terminal hexa histidine-tagged hTFIIE&#x003b1; (6H&#x02013;hTFIIE&#x003b1;) expression plasmid. The <italic>Nde</italic>I&#x02013;<italic>Bam</italic>HI fragment of mutated hTFIIH p62 cDNA was subcloned into the pET vector making the N-terminal FLAG-tagged hTFIIH p62 PH-D (FLAG&#x02013;p62 PH) expression plasmid.</p></sec><sec disp-level="2"><title>Purification of hTFIIE<italic>&#x003b1;</italic> AC-D and hTFIIH p62 PH-D</title><p>hTFIIE&#x003b1; AC-D (residues 378&#x02013;439) was expressed as an hexa histidine-tagged product in pET3a vectors (Novagen) in <italic>E. coli</italic> BL21(DE3)pLysS (Novagen). Lysed supernatant was loaded onto the Ni-NTA-agarose (Qiagen) column. The eluate was then applied onto Q-Sepharose (GE Healthcare). After digestion with thrombin to remove the 6H tag, sample was again loaded onto the Ni-NTA agarose column. Fractions passing through the column were concentrated and applied onto Superdex30 (GE Healthcare). hTFIIH p62 PH-D was purified as described (<xref ref-type="bibr" rid="b16">Gervais <italic>et al</italic>, 2004</xref>).</p></sec><sec disp-level="2"><title>NMR spectroscopy</title><p>Measurements of NMR spectra, structural calculations and NMR titration experiments are described in <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>.</p></sec><sec disp-level="2"><title>Purification of recombinant proteins</title><p>Recombinant point mutant hTFIIE&#x003b1; proteins were expressed in <italic>E. coli</italic> Rosetta&#x02122;(DE3)pLysS (Novagen), and recombinant hTFIIH p62 point mutants were expressed in BL21(DE3)pLysS by induction with isopropyl-&#x003b2;-<sc>D</sc>-thiogalactopyranoside (<xref ref-type="bibr" rid="b44">Studier <italic>et al</italic>, 1990</xref>). The purification method of these recombinant proteins was as described previously (<xref ref-type="bibr" rid="b47">Watanabe <italic>et al</italic>, 2003</xref>). Typical preparations were &#x0003e;90&#x00025; pure, judging by Coomassie blue staining of an SDS&#x02013;polyacrylamide gel.</p></sec><sec disp-level="2"><title>GST pull-down assay</title><p>GST fusion proteins were used for protein interaction assays (<xref ref-type="bibr" rid="b35">Okamoto <italic>et al</italic>, 1998</xref>). The bound proteins were released by boiling in SDS&#x02013;PAGE loading buffer, separated by SDS&#x02013;PAGE and detected by western blotting with anti-hTFIIE&#x003b1; rabbit antiserum (1:3000 dilution), anti-FLAG M2 monoclonal antibody (Sigma) and anti-p53 (DO-1) (Santa Cruz) using the enhanced chemiluminescence detection system (GE Healthcare).</p></sec><sec disp-level="2"><title><italic>In vitro</italic> transcription assay</title><p>Recombinant GTFs as well as native Pol II and hTFIIH were purified as described previously (<xref ref-type="bibr" rid="b47">Watanabe <italic>et al</italic>, 2003</xref>). <italic>In vitro</italic> transcription was performed as described (<xref ref-type="bibr" rid="b31">Ohkuma <italic>et al</italic>, 1995</xref>). The plasmid pML(C<sub>2</sub>AT)&#x00394;-50 containing the adenovirus 2 major late promoter, which gives a 390-nt transcript, was used as either a supercoiled or a linearized template for basal transcription assays (<xref ref-type="bibr" rid="b49">Yamamoto <italic>et al</italic>, 2001</xref>). To prepare the linearized template, pML(C<sub>2</sub>AT)&#x00394;-50 was digested with <italic>Sma</italic>I. After transcription, radiolabeled transcripts were subjected to urea&#x02013;PAGE and detected by autoradiography. The transcripts were quantified by a Fuji BAS5000 Bio-Imaging Analyzer. Relative transcription activities of the mutant hTFIIE&#x003b1; proteins were calculated by defining the transcription activity of the wild-type hTFIIE&#x003b1; as 100&#x00025;.</p></sec><sec disp-level="2"><title>Kinase assay</title><p>In addition to transcription factors added as described in the legend of <xref ref-type="fig" rid="f4">Figure 4D</xref>, the kinase reaction mixture (25 &#x003bc;l) contained 5 mM HEPES-KOH (pH 7.8), 20 mM Tris&#x02013;HCl (pH 7.9 at 4&#x000b0;C), 7 mM MgCl<sub>2</sub>, 60 mM KCl, 12&#x00025; (v/v) glycerol, 2&#x00025; (w/v) polyethylene glycol 8000, 2 mM 2-mercaptoethanol, 0.1 mM EDTA, 240 &#x003bc;g/ml of bovine serum albumin, 5 &#x003bc;M ATP and 3 &#x003bc;Ci of [&#x003b3;-<sup>32</sup>P]ATP. Phosphorylation reactions were carried out at 30&#x000b0;C for 1 h and stopped by addition of 75 &#x003bc;l of phosphorylation stop solution (10 mM EDTA, 0.1&#x00025; NP40 and 0.05&#x00025; SDS). Phosphorylated proteins were precipitated with TCA, analysed by SDS&#x02013;PAGE (5.5&#x00025; acrylamide), and detected by autoradiography with Fuji RX-U X-ray film.</p></sec><sec disp-level="2"><title>Accession numbers</title><p>Coordinates of hTFIIE&#x003b1; AC-D free and in complex with hTFIIH p62 PH-D have been deposited in the Protein Data Bank (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.rcsb.org">www.rcsb.org</ext-link>) under accession codes 2RNQ and 2RNR, respectively.</p></sec></sec><sec sec-type="supplementary-material" id="S1"><title>Supplementary Material</title><supplementary-material id="N0x1c6ad80N0x3357560" content-type="local-data"><caption><p>Supplementary Information</p></caption><media mimetype="application" mime-subtype="pdf" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj200847s1.pdf"/></supplementary-material></sec></body><back><ack><p>We thank MEXT for support through a Protein 3000 Project, Transcription and Translation grant, a Target Proteins Research Program grant, and Grants in Aid for Scientific Research (MO, YO and YN), and JST for support through Collaborative of Regional Entities for the Advancement of Technological Excellence (CREATE) (MO and YN). We thank Dr Saburo Aimoto for his kind gift of the synthetic hTFIIE&#x003b1; AC-D<sub>381&#x02212;394</sub> peptide.</p></ack><ref-list><ref id="b1"><citation citation-type="journal"><name><surname>Bochkareva</surname><given-names>E</given-names></name>, <name><surname>Kaustov</surname><given-names>L</given-names></name>, <name><surname>Ayed</surname><given-names>A</given-names></name>, <name><surname>Yi</surname><given-names>GS</given-names></name>, <name><surname>Lu</surname><given-names>Y</given-names></name>, <name><surname>Pineda-Lucena</surname><given-names>A</given-names></name>, <name><surname>Liao</surname><given-names>JC</given-names></name>, <name><surname>Okorokov</surname><given-names>AL</given-names></name>, <name><surname>Milner</surname><given-names>J</given-names></name>, <name><surname>Arrowsmith</surname><given-names>CH</given-names></name>, <name><surname>Bochkarev</surname><given-names>A</given-names></name> (<year>2005</year>) <article-title>Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A</article-title>. <source>Proc Natl Acad Sci USA</source><volume>102</volume>: <fpage>15412</fpage>&#x02013;<lpage>15417</lpage><pub-id pub-id-type="pmid">16234232</pub-id></citation></ref><ref id="b2"><citation citation-type="journal"><name><surname>Burley</surname><given-names>SK</given-names></name>, <name><surname>Petsko</surname><given-names>GA</given-names></name> (<year>1986</year>) <article-title>Amino-aromatic interactions in proteins</article-title>. <source>FEBS Lett</source><volume>203</volume>: <fpage>139</fpage>&#x02013;<lpage>143</lpage><pub-id pub-id-type="pmid">3089835</pub-id></citation></ref><ref id="b3"><citation citation-type="journal"><name><surname>Bushnell</surname><given-names>DA</given-names></name>, <name><surname>Bamdad</surname><given-names>C</given-names></name>, <name><surname>Kornberg</surname><given-names>RD</given-names></name> (<year>1996</year>) <article-title>A minimal set of RNA polymerase II transcription protein interactions</article-title>. <source>J Biol Chem</source><volume>271</volume>: <fpage>20170</fpage>&#x02013;<lpage>20174</lpage><pub-id pub-id-type="pmid">8702741</pub-id></citation></ref><ref id="b4"><citation citation-type="journal"><name><surname>Bushnell</surname><given-names>DA</given-names></name>, <name><surname>Westover</surname><given-names>KD</given-names></name>, <name><surname>Davis</surname><given-names>RE</given-names></name>, <name><surname>Kornberg</surname><given-names>RD</given-names></name> (<year>2004</year>) <article-title>Structural basis of transcription: an RNA polymerase II&#x02013;TFIIB cocrystal at 4.5 Angstroms</article-title>. <source>Science</source><volume>303</volume>: <fpage>983</fpage>&#x02013;<lpage>988</lpage><pub-id pub-id-type="pmid">14963322</pub-id></citation></ref><ref id="b5"><citation citation-type="journal"><name><surname>Chen</surname><given-names>D</given-names></name>, <name><surname>Riedl</surname><given-names>T</given-names></name>, <name><surname>Washbrook</surname><given-names>E</given-names></name>, <name><surname>Pace</surname><given-names>PE</given-names></name>, <name><surname>Coombes</surname><given-names>RC</given-names></name>, <name><surname>Egly</surname><given-names>JM</given-names></name>, <name><surname>Ali</surname><given-names>S</given-names></name> (<year>2000</year>) <article-title>Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7</article-title>. <source>Mol Cell</source><volume>6</volume>: <fpage>127</fpage>&#x02013;<lpage>137</lpage><pub-id pub-id-type="pmid">10949034</pub-id></citation></ref><ref id="b6"><citation citation-type="journal"><name><surname>Cramer</surname><given-names>P</given-names></name>, <name><surname>Bushnell</surname><given-names>DA</given-names></name>, <name><surname>Fu</surname><given-names>J</given-names></name>, <name><surname>Gnatt</surname><given-names>AL</given-names></name>, <name><surname>Maier-Davis</surname><given-names>B</given-names></name>, <name><surname>Thompson</surname><given-names>NE</given-names></name>, <name><surname>Burgess</surname><given-names>RR</given-names></name>, <name><surname>Edwards</surname><given-names>AM</given-names></name>, <name><surname>David</surname><given-names>PR</given-names></name>, <name><surname>Kornberg</surname><given-names>RD</given-names></name> (<year>2000</year>) <article-title>Architecture of RNA polymerase II and implications for the transcription mechanism</article-title>. <source>Science</source><volume>288</volume>: <fpage>640</fpage>&#x02013;<lpage>649</lpage><pub-id pub-id-type="pmid">10784442</pub-id></citation></ref><ref id="b7"><citation citation-type="journal"><name><surname>Cramer</surname><given-names>P</given-names></name>, <name><surname>Bushnell</surname><given-names>DA</given-names></name>, <name><surname>Kornberg</surname><given-names>RD</given-names></name> (<year>2001</year>) <article-title>Structural basis of transcription: RNA polymerase II at 2.8 Angstrom resolution</article-title>. <source>Science</source><volume>292</volume>: <fpage>1863</fpage>&#x02013;<lpage>1876</lpage><pub-id pub-id-type="pmid">11313498</pub-id></citation></ref><ref id="b8"><citation citation-type="journal"><name><surname>Di Lello</surname><given-names>P</given-names></name>, <name><surname>Miller Jenkins</surname><given-names>LM</given-names></name>, <name><surname>Jones</surname><given-names>TN</given-names></name>, <name><surname>Nguyen</surname><given-names>BD</given-names></name>, <name><surname>Hara</surname><given-names>T</given-names></name>, <name><surname>Yamaguchi</surname><given-names>H</given-names></name>, <name><surname>Dikeakos</surname><given-names>JD</given-names></name>, <name><surname>Appella</surname><given-names>E</given-names></name>, <name><surname>Legault</surname><given-names>P</given-names></name>, <name><surname>Omichinski</surname><given-names>JG</given-names></name> (<year>2006</year>) <article-title>Structure of the Tfb1/p53 complex: insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53</article-title>. <source>Mol Cell</source><volume>22</volume>: <fpage>731</fpage>&#x02013;<lpage>740</lpage><pub-id pub-id-type="pmid">16793543</pub-id></citation></ref><ref id="b9"><citation citation-type="journal"><name><surname>Di Lello</surname><given-names>P</given-names></name>, <name><surname>Miller Jenkins</surname><given-names>LM</given-names></name>, <name><surname>Mas</surname><given-names>C</given-names></name>, <name><surname>Langlois</surname><given-names>C</given-names></name>, <name><surname>Malitskaya</surname><given-names>E</given-names></name>, <name><surname>Fradet-Turcotte</surname><given-names>A</given-names></name>, <name><surname>Archambault</surname><given-names>J</given-names></name>, <name><surname>Legault</surname><given-names>P</given-names></name>, <name><surname>Omichinski</surname><given-names>JG</given-names></name> (<year>2008</year>) <article-title>p53 and TFIIE&#x003b1; share a common binding site on the Tfb1/p62 subunit of TFIIH</article-title>. <source>Proc Natl Acad Sci USA</source><volume>105</volume>: <fpage>106</fpage>&#x02013;<lpage>111</lpage><pub-id pub-id-type="pmid">18160537</pub-id></citation></ref><ref id="b10"><citation citation-type="journal"><name><surname>Di Lello</surname><given-names>P</given-names></name>, <name><surname>Nguyen</surname><given-names>BD</given-names></name>, <name><surname>Jones</surname><given-names>TN</given-names></name>, <name><surname>Potempa</surname><given-names>K</given-names></name>, <name><surname>Kobor</surname><given-names>MS</given-names></name>, <name><surname>Legault</surname><given-names>P</given-names></name>, <name><surname>Omichinski</surname><given-names>JG</given-names></name> (<year>2005</year>) <article-title>NMR structure of the amino-terminal domain from the Tfb1 subunit of TFIIH and characterization of its phosphoinositide and VP16 binding sites</article-title>. <source>Biochemistry</source><volume>44</volume>: <fpage>7678</fpage>&#x02013;<lpage>7686</lpage><pub-id pub-id-type="pmid">15909982</pub-id></citation></ref><ref id="b11"><citation citation-type="journal"><name><surname>Doerks</surname><given-names>T</given-names></name>, <name><surname>Huber</surname><given-names>S</given-names></name>, <name><surname>Buchner</surname><given-names>E</given-names></name>, <name><surname>Bork</surname><given-names>P</given-names></name> (<year>2002</year>) <article-title>BSD: a novel domain in transcription factors and synapse-associated proteins</article-title>. <source>Trends Biochem Sci</source><volume>27</volume>: <fpage>168</fpage>&#x02013;<lpage>170</lpage><pub-id pub-id-type="pmid">11943536</pub-id></citation></ref><ref id="b12"><citation citation-type="journal"><name><surname>Douziech</surname><given-names>M</given-names></name>, <name><surname>Coin</surname><given-names>F</given-names></name>, <name><surname>Chipoulet</surname><given-names>JM</given-names></name>, <name><surname>Arai</surname><given-names>Y</given-names></name>, <name><surname>Ohkuma</surname><given-names>Y</given-names></name>, <name><surname>Egly</surname><given-names>J-M</given-names></name>, <name><surname>Coulombe</surname><given-names>B</given-names></name> (<year>2000</year>) <article-title>Mechanism of promoter melting by the xeroderma pigmentosum complementation group B helicase of transcription factor IIH revealed by protein&#x02013;DNA photo-crosslinking</article-title>. <source>Mol Cell Biol</source><volume>20</volume>: <fpage>8168</fpage>&#x02013;<lpage>8177</lpage><pub-id pub-id-type="pmid">11027286</pub-id></citation></ref><ref id="b13"><citation citation-type="journal"><name><surname>Drapkin</surname><given-names>R</given-names></name>, <name><surname>Reardon</surname><given-names>JT</given-names></name>, <name><surname>Ansari</surname><given-names>A</given-names></name>, <name><surname>Huang</surname><given-names>JC</given-names></name>, <name><surname>Zawel</surname><given-names>L</given-names></name>, <name><surname>Ahn</surname><given-names>K</given-names></name>, <name><surname>Sancar</surname><given-names>A</given-names></name>, <name><surname>Reinberg</surname><given-names>D</given-names></name> (<year>1994</year>) <article-title>Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II</article-title>. <source>Nature</source><volume>368</volume>: <fpage>769</fpage>&#x02013;<lpage>772</lpage><pub-id pub-id-type="pmid">8152490</pub-id></citation></ref><ref id="b14"><citation citation-type="journal"><name><surname>Dvir</surname><given-names>A</given-names></name>, <name><surname>Garrett</surname><given-names>KP</given-names></name>, <name><surname>Chalut</surname><given-names>C</given-names></name>, <name><surname>Egly</surname><given-names>J-M</given-names></name>, <name><surname>Conaway</surname><given-names>JW</given-names></name>, <name><surname>Conaway</surname><given-names>RC</given-names></name> (<year>1996</year>) <article-title>A role for ATP and TFIIH in activation of the RNA polymerase II preinitiation complex prior to transcription initiation</article-title>. <source>J Biol Chem</source><volume>271</volume>: <fpage>7245</fpage>&#x02013;<lpage>7248</lpage><pub-id pub-id-type="pmid">8631733</pub-id></citation></ref><ref id="b15"><citation citation-type="journal"><name><surname>Dyson</surname><given-names>HJ</given-names></name>, <name><surname>Wright</surname><given-names>PE</given-names></name> (<year>2002</year>) <article-title>Coupling of folding and binding for unstructured proteins</article-title>. <source>Curr Opin Struct Biol</source><volume>12</volume>: <fpage>54</fpage>&#x02013;<lpage>60</lpage><pub-id pub-id-type="pmid">11839490</pub-id></citation></ref><ref id="b16"><citation citation-type="journal"><name><surname>Gervais</surname><given-names>V</given-names></name>, <name><surname>Lamour</surname><given-names>V</given-names></name>, <name><surname>Jawhari</surname><given-names>A</given-names></name>, <name><surname>Frindel</surname><given-names>F</given-names></name>, <name><surname>Wasielewski</surname><given-names>E</given-names></name>, <name><surname>Dubaele</surname><given-names>S</given-names></name>, <name><surname>Egly</surname><given-names>JM</given-names></name>, <name><surname>Thierry</surname><given-names>JC</given-names></name>, <name><surname>Kieffer</surname><given-names>B</given-names></name>, <name><surname>Poterszman</surname><given-names>A</given-names></name> (<year>2004</year>) <article-title>TFIIH contains a PH domain involved in DNA nucleotide excision repair</article-title>. <source>Nat Struct Mol Biol</source><volume>11</volume>: <fpage>616</fpage>&#x02013;<lpage>622</lpage><pub-id pub-id-type="pmid">15195146</pub-id></citation></ref><ref id="b17"><citation citation-type="journal"><name><surname>Giglia-Mari</surname><given-names>G</given-names></name>, <name><surname>Coin</surname><given-names>F</given-names></name>, <name><surname>Ranish</surname><given-names>JA</given-names></name>, <name><surname>Hoogstraten</surname><given-names>D</given-names></name>, <name><surname>Theil</surname><given-names>A</given-names></name>, <name><surname>Wijgers</surname><given-names>N</given-names></name>, <name><surname>Jaspers</surname><given-names>NG</given-names></name>, <name><surname>Raams</surname><given-names>A</given-names></name>, <name><surname>Argentini</surname><given-names>M</given-names></name>, <name><surname>van der Spek</surname><given-names>PJ</given-names></name>, <name><surname>Botta</surname><given-names>E</given-names></name>, <name><surname>Stefanini</surname><given-names>M</given-names></name>, <name><surname>Egly</surname><given-names>JM</given-names></name>, <name><surname>Aebersold</surname><given-names>R</given-names></name>, <name><surname>Hoeijmakers</surname><given-names>JH</given-names></name>, <name><surname>Vermeulen</surname><given-names>W</given-names></name> (<year>2004</year>) <article-title>A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A</article-title>. <source>Nat Genet</source><volume>36</volume>: <fpage>714</fpage>&#x02013;<lpage>719</lpage><pub-id pub-id-type="pmid">15220921</pub-id></citation></ref><ref id="b18"><citation citation-type="journal"><name><surname>Holstege</surname><given-names>FCP</given-names></name>, <name><surname>van der Vliet</surname><given-names>PC</given-names></name>, <name><surname>Timmers</surname><given-names>HTM</given-names></name> (<year>1996</year>) <article-title>Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH</article-title>. <source>EMBO J</source><volume>15</volume>: <fpage>1666</fpage>&#x02013;<lpage>1677</lpage><pub-id pub-id-type="pmid">8612591</pub-id></citation></ref><ref id="b19"><citation citation-type="journal"><name><surname>Itoh</surname><given-names>Y</given-names></name>, <name><surname>Unzai</surname><given-names>S</given-names></name>, <name><surname>Sato</surname><given-names>M</given-names></name>, <name><surname>Nagadoi</surname><given-names>A</given-names></name>, <name><surname>Okuda</surname><given-names>M</given-names></name>, <name><surname>Nishimura</surname><given-names>Y</given-names></name>, <name><surname>Akashi</surname><given-names>S</given-names></name> (<year>2005</year>) <article-title>Investigation of molecular size of transcription factor TFIIE in solution</article-title>. <source>Proteins</source><volume>61</volume>: <fpage>633</fpage>&#x02013;<lpage>641</lpage><pub-id pub-id-type="pmid">16184598</pub-id></citation></ref><ref id="b20"><citation citation-type="journal"><name><surname>Jawhari</surname><given-names>A</given-names></name>, <name><surname>Boussert</surname><given-names>S</given-names></name>, <name><surname>Lamour</surname><given-names>V</given-names></name>, <name><surname>Atkinson</surname><given-names>RA</given-names></name>, <name><surname>Kieffer</surname><given-names>B</given-names></name>, <name><surname>Poch</surname><given-names>O</given-names></name>, <name><surname>Potier</surname><given-names>N</given-names></name>, <name><surname>van Dorsselaer</surname><given-names>A</given-names></name>, <name><surname>Moras</surname><given-names>D</given-names></name>, <name><surname>Poterszman</surname><given-names>A</given-names></name> (<year>2004</year>) <article-title>Domain architecture of the p62 subunit from the human transcription/repair factor TFIIH deduced by limited proteolysis and mass spectrometry analysis</article-title>. <source>Biochemistry</source><volume>43</volume>: <fpage>14420</fpage>&#x02013;<lpage>14430</lpage><pub-id pub-id-type="pmid">15533047</pub-id></citation></ref><ref id="b21"><citation citation-type="journal"><name><surname>Jawhari</surname><given-names>A</given-names></name>, <name><surname>Uhring</surname><given-names>M</given-names></name>, <name><surname>De Carlo</surname><given-names>S</given-names></name>, <name><surname>Crucifix</surname><given-names>C</given-names></name>, <name><surname>Tocchini-Valentini</surname><given-names>G</given-names></name>, <name><surname>Moras</surname><given-names>D</given-names></name>, <name><surname>Schultz</surname><given-names>P</given-names></name>, <name><surname>Poterszman</surname><given-names>A</given-names></name> (<year>2006</year>) <article-title>Structure and oligomeric state of human transcription factor TFIIE</article-title>. <source>EMBO Rep</source><volume>7</volume>: <fpage>500</fpage>&#x02013;<lpage>505</lpage><pub-id pub-id-type="pmid">16547462</pub-id></citation></ref><ref id="b22"><citation citation-type="journal"><name><surname>Kastan</surname><given-names>MB</given-names></name>, <name><surname>Onyekwere</surname><given-names>O</given-names></name>, <name><surname>Sidransky</surname><given-names>D</given-names></name>, <name><surname>Vogelstein</surname><given-names>B</given-names></name>, <name><surname>Craig</surname><given-names>RW</given-names></name> (<year>1991</year>) <article-title>Participation of p53 protein in the cellular response to DNA damage</article-title>. <source>Cancer Res</source><volume>51</volume>: <fpage>6304</fpage>&#x02013;<lpage>6311</lpage><pub-id pub-id-type="pmid">1933891</pub-id></citation></ref><ref id="b23"><citation citation-type="journal"><name><surname>Kim</surname><given-names>JL</given-names></name>, <name><surname>Nikolov</surname><given-names>DB</given-names></name>, <name><surname>Burley</surname><given-names>SK</given-names></name> (<year>1993a</year>) <article-title>Co-crystal structure of TBP recognizing the minor groove of a TATA element</article-title>. <source>Nature</source><volume>365</volume>: <fpage>520</fpage>&#x02013;<lpage>527</lpage><pub-id pub-id-type="pmid">8413605</pub-id></citation></ref><ref id="b24"><citation citation-type="journal"><name><surname>Kim</surname><given-names>Y</given-names></name>, <name><surname>Geiger</surname><given-names>JH</given-names></name>, <name><surname>Hahn</surname><given-names>S</given-names></name>, <name><surname>Sigler</surname><given-names>PB</given-names></name> (<year>1993b</year>) <article-title>Crystal structure of a yeast TBP/TATA-box complex</article-title>. <source>Nature</source><volume>365</volume>: <fpage>512</fpage>&#x02013;<lpage>520</lpage><pub-id pub-id-type="pmid">8413604</pub-id></citation></ref><ref id="b25"><citation citation-type="journal"><name><surname>Kuldell</surname><given-names>NH</given-names></name>, <name><surname>Buratowski</surname><given-names>S</given-names></name> (<year>1997</year>) <article-title>Genetic analysis of the large subunit of yeast transcription factor IIE reveals two regions with distinct functions</article-title>. <source>Mol Cell Biol</source><volume>17</volume>: <fpage>5288</fpage>&#x02013;<lpage>5298</lpage><pub-id pub-id-type="pmid">9271406</pub-id></citation></ref><ref id="b26"><citation citation-type="journal"><name><surname>Kunkel</surname><given-names>TA</given-names></name>, <name><surname>Roberts</surname><given-names>JD</given-names></name>, <name><surname>Zakour</surname><given-names>RA</given-names></name> (<year>1987</year>) <article-title>Rapid and efficient site-specific mutagenesis without phenotypic selections</article-title>. <source>Methods Enzymol</source><volume>154</volume>: <fpage>367</fpage>&#x02013;<lpage>382</lpage><pub-id pub-id-type="pmid">3323813</pub-id></citation></ref><ref id="b27"><citation citation-type="journal"><name><surname>Kussie</surname><given-names>PH</given-names></name>, <name><surname>Gorina</surname><given-names>S</given-names></name>, <name><surname>Marechal</surname><given-names>V</given-names></name>, <name><surname>Elenbaas</surname><given-names>B</given-names></name>, <name><surname>Moreau</surname><given-names>J</given-names></name>, <name><surname>Levine</surname><given-names>AJ</given-names></name>, <name><surname>Pavletich</surname><given-names>NP</given-names></name> (<year>1996</year>) <article-title>Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</article-title>. <source>Science</source><volume>274</volume>: <fpage>948</fpage>&#x02013;<lpage>953</lpage><pub-id pub-id-type="pmid">8875929</pub-id></citation></ref><ref id="b28"><citation citation-type="journal"><name><surname>Lu</surname><given-names>H</given-names></name>, <name><surname>Zawel</surname><given-names>L</given-names></name>, <name><surname>Fisher</surname><given-names>L</given-names></name>, <name><surname>Egly</surname><given-names>J-M</given-names></name>, <name><surname>Reinberg</surname><given-names>D</given-names></name> (<year>1992</year>) <article-title>Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II</article-title>. <source>Nature</source><volume>358</volume>: <fpage>641</fpage>&#x02013;<lpage>645</lpage><pub-id pub-id-type="pmid">1495560</pub-id></citation></ref><ref id="b29"><citation citation-type="journal"><name><surname>Nikolov</surname><given-names>DB</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Halay</surname><given-names>ED</given-names></name>, <name><surname>Usheva</surname><given-names>AA</given-names></name>, <name><surname>Hisatake</surname><given-names>K</given-names></name>, <name><surname>Lee</surname><given-names>DK</given-names></name>, <name><surname>Roeder</surname><given-names>RG</given-names></name>, <name><surname>Burley</surname><given-names>SK</given-names></name> (<year>1995</year>) <article-title>Crystal structure of a TFIIB&#x02013;TBP&#x02013;TATA-element ternary complex</article-title>. <source>Nature</source><volume>377</volume>: <fpage>119</fpage>&#x02013;<lpage>128</lpage><pub-id pub-id-type="pmid">7675079</pub-id></citation></ref><ref id="b30"><citation citation-type="journal"><name><surname>Nikolov</surname><given-names>DB</given-names></name>, <name><surname>Hu</surname><given-names>SH</given-names></name>, <name><surname>Lin</surname><given-names>J</given-names></name>, <name><surname>Gasch</surname><given-names>A</given-names></name>, <name><surname>Hoffmann</surname><given-names>A</given-names></name>, <name><surname>Horikoshi</surname><given-names>M</given-names></name>, <name><surname>Chua</surname><given-names>NH</given-names></name>, <name><surname>Roeder</surname><given-names>RG</given-names></name>, <name><surname>Burley</surname><given-names>SK</given-names></name> (<year>1992</year>) <article-title>Crystal structure of TFIID TATA-box binding protein</article-title>. <source>Nature</source><volume>360</volume>: <fpage>40</fpage>&#x02013;<lpage>46</lpage><pub-id pub-id-type="pmid">1436073</pub-id></citation></ref><ref id="b31"><citation citation-type="journal"><name><surname>Ohkuma</surname><given-names>Y</given-names></name>, <name><surname>Hashimoto</surname><given-names>S</given-names></name>, <name><surname>Wang</surname><given-names>CK</given-names></name>, <name><surname>Horikoshi</surname><given-names>M</given-names></name>, <name><surname>Roeder</surname><given-names>RG</given-names></name> (<year>1995</year>) <article-title>Analysis of the role of TFIIE in basal transcription and TFIIH-mediated carboxy-terminal domain phosphorylation through structure&#x02013;function studies of TFIIE-&#x003b1;</article-title>. <source>Mol Cell Biol</source><volume>15</volume>: <fpage>4856</fpage>&#x02013;<lpage>4866</lpage><pub-id pub-id-type="pmid">7651404</pub-id></citation></ref><ref id="b32"><citation citation-type="journal"><name><surname>Ohkuma</surname><given-names>Y</given-names></name>, <name><surname>Roeder</surname><given-names>RG</given-names></name> (<year>1994</year>) <article-title>Regulation of TFIIH ATPase and kinase activities by TFIIE during active initiation complex formation</article-title>. <source>Nature</source><volume>368</volume>: <fpage>160</fpage>&#x02013;<lpage>163</lpage><pub-id pub-id-type="pmid">8166891</pub-id></citation></ref><ref id="b33"><citation citation-type="journal"><name><surname>Ohkuma</surname><given-names>Y</given-names></name>, <name><surname>Sumimoto</surname><given-names>H</given-names></name>, <name><surname>Hoffmann</surname><given-names>A</given-names></name>, <name><surname>Shimasaki</surname><given-names>S</given-names></name>, <name><surname>Horikoshi</surname><given-names>M</given-names></name>, <name><surname>Roeder</surname><given-names>RG</given-names></name> (<year>1991</year>) <article-title>Structural motifs and potential &#x003c3; homologies in the large subunit of human general transcription factor TFIIE</article-title>. <source>Nature</source><volume>354</volume>: <fpage>398</fpage>&#x02013;<lpage>401</lpage><pub-id pub-id-type="pmid">1956403</pub-id></citation></ref><ref id="b34"><citation citation-type="journal"><name><surname>Ohkuma</surname><given-names>Y</given-names></name>, <name><surname>Sumimoto</surname><given-names>H</given-names></name>, <name><surname>Horikoshi</surname><given-names>M</given-names></name>, <name><surname>Roeder</surname><given-names>RG</given-names></name> (<year>1990</year>) <article-title>Factors involved in specific transcription by mammalian RNA polymerase II: purification and characterization of general transcription factor TFIIE</article-title>. <source>Proc Natl Acad Sci USA</source><volume>87</volume>: <fpage>9163</fpage>&#x02013;<lpage>9167</lpage><pub-id pub-id-type="pmid">2251258</pub-id></citation></ref><ref id="b35"><citation citation-type="journal"><name><surname>Okamoto</surname><given-names>T</given-names></name>, <name><surname>Yamamoto</surname><given-names>S</given-names></name>, <name><surname>Watanabe</surname><given-names>Y</given-names></name>, <name><surname>Ohta</surname><given-names>T</given-names></name>, <name><surname>Hanaoka</surname><given-names>F</given-names></name>, <name><surname>Roeder</surname><given-names>RG</given-names></name>, <name><surname>Ohkuma</surname><given-names>Y</given-names></name> (<year>1998</year>) <article-title>Analysis of the role of TFIIE in transcriptional regulation through structure&#x02013;function studies of the TFIIE&#x003b2; subunit</article-title>. <source>J Biol Chem</source><volume>273</volume>: <fpage>19866</fpage>&#x02013;<lpage>19876</lpage><pub-id pub-id-type="pmid">9677423</pub-id></citation></ref><ref id="b36"><citation citation-type="journal"><name><surname>Okuda</surname><given-names>M</given-names></name>, <name><surname>Tanaka</surname><given-names>A</given-names></name>, <name><surname>Arai</surname><given-names>Y</given-names></name>, <name><surname>Satoh</surname><given-names>M</given-names></name>, <name><surname>Okamura</surname><given-names>H</given-names></name>, <name><surname>Nagadoi</surname><given-names>A</given-names></name>, <name><surname>Hanaoka</surname><given-names>F</given-names></name>, <name><surname>Ohkuma</surname><given-names>Y</given-names></name>, <name><surname>Nishimura</surname><given-names>Y</given-names></name> (<year>2004</year>) <article-title>A novel zinc finger structure in the large subunit of human general transcription factor TFIIE</article-title>. <source>J Biol Chem</source><volume>279</volume>: <fpage>51395</fpage>&#x02013;<lpage>51403</lpage><pub-id pub-id-type="pmid">15385556</pub-id></citation></ref><ref id="b37"><citation citation-type="journal"><name><surname>Okuda</surname><given-names>M</given-names></name>, <name><surname>Watanabe</surname><given-names>Y</given-names></name>, <name><surname>Okamura</surname><given-names>H</given-names></name>, <name><surname>Hanaoka</surname><given-names>F</given-names></name>, <name><surname>Ohkuma</surname><given-names>Y</given-names></name>, <name><surname>Nishimura</surname><given-names>Y</given-names></name> (<year>2000</year>) <article-title>Structure of the central core domain of TFIIE&#x003b2; with a novel double-stranded DNA-binding</article-title>. <source>EMBO J</source><volume>19</volume>: <fpage>1346</fpage>&#x02013;<lpage>1356</lpage><pub-id pub-id-type="pmid">10716934</pub-id></citation></ref><ref id="b38"><citation citation-type="journal"><name><surname>Orphanides</surname><given-names>G</given-names></name>, <name><surname>Lagrange</surname><given-names>T</given-names></name>, <name><surname>Reinberg</surname><given-names>D</given-names></name> (<year>1996</year>) <article-title>The general transcription factors of RNA polymerase II</article-title>. <source>Genes Dev</source><volume>10</volume>: <fpage>2657</fpage>&#x02013;<lpage>2683</lpage><pub-id pub-id-type="pmid">8946909</pub-id></citation></ref><ref id="b39"><citation citation-type="journal"><name><surname>Pearson</surname><given-names>A</given-names></name>, <name><surname>Greenblatt</surname><given-names>J</given-names></name> (<year>1997</year>) <article-title>Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH</article-title>. <source>Oncogene</source><volume>15</volume>: <fpage>2643</fpage>&#x02013;<lpage>2658</lpage><pub-id pub-id-type="pmid">9400991</pub-id></citation></ref><ref id="b40"><citation citation-type="journal"><name><surname>Peterson</surname><given-names>MG</given-names></name>, <name><surname>Inostroza</surname><given-names>J</given-names></name>, <name><surname>Maxon</surname><given-names>ME</given-names></name>, <name><surname>Flores</surname><given-names>O</given-names></name>, <name><surname>Admon</surname><given-names>A</given-names></name>, <name><surname>Reinberg</surname><given-names>D</given-names></name>, <name><surname>Tjian</surname><given-names>R</given-names></name> (<year>1991</year>) <article-title>Structure and functional properties of human general transcription factor IIE</article-title>. <source>Nature</source><volume>354</volume>: <fpage>369</fpage>&#x02013;<lpage>373</lpage><pub-id pub-id-type="pmid">1956398</pub-id></citation></ref><ref id="b41"><citation citation-type="journal"><name><surname>Ptashne</surname><given-names>M</given-names></name>, <name><surname>Gann</surname><given-names>A</given-names></name> (<year>1997</year>) <article-title>Transcriptional activation by recruitment</article-title>. <source>Nature</source><volume>386</volume>: <fpage>569</fpage>&#x02013;<lpage>577</lpage><pub-id pub-id-type="pmid">9121580</pub-id></citation></ref><ref id="b42"><citation citation-type="journal"><name><surname>Roeder</surname><given-names>RG</given-names></name> (<year>1996</year>) <article-title>The role of general initiation factors in transcription by RNA polymerase II</article-title>. <source>Trends Biochem Sci</source><volume>21</volume>: <fpage>327</fpage>&#x02013;<lpage>335</lpage><pub-id pub-id-type="pmid">8870495</pub-id></citation></ref><ref id="b43"><citation citation-type="journal"><name><surname>Schultz</surname><given-names>P</given-names></name>, <name><surname>Fribourg</surname><given-names>S</given-names></name>, <name><surname>Poterszman</surname><given-names>A</given-names></name>, <name><surname>Mallouh</surname><given-names>V</given-names></name>, <name><surname>Moras</surname><given-names>D</given-names></name>, <name><surname>Egly</surname><given-names>JM</given-names></name> (<year>2000</year>) <article-title>Molecular structure of human TFIIH</article-title>. <source>Cell</source><volume>102</volume>: <fpage>599</fpage>&#x02013;<lpage>607</lpage><pub-id pub-id-type="pmid">11007478</pub-id></citation></ref><ref id="b44"><citation citation-type="journal"><name><surname>Studier</surname><given-names>FW</given-names></name>, <name><surname>Rosenberg</surname><given-names>AH</given-names></name>, <name><surname>Dunn</surname><given-names>JJ</given-names></name>, <name><surname>Dubendorff</surname><given-names>JW</given-names></name> (<year>1990</year>) <article-title>Use of T7 RNA polymerase to direct expression of cloned genes</article-title>. <source>Methods Enzymol</source><volume>185</volume>: <fpage>60</fpage>&#x02013;<lpage>89</lpage><pub-id pub-id-type="pmid">2199796</pub-id></citation></ref><ref id="b45"><citation citation-type="journal"><name><surname>Sumimoto</surname><given-names>H</given-names></name>, <name><surname>Ohkuma</surname><given-names>Y</given-names></name>, <name><surname>Sinn</surname><given-names>E</given-names></name>, <name><surname>Kato</surname><given-names>H</given-names></name>, <name><surname>Shimasaki</surname><given-names>S</given-names></name>, <name><surname>Horikoshi</surname><given-names>M</given-names></name>, <name><surname>Roeder</surname><given-names>RG</given-names></name> (<year>1991</year>) <article-title>Conserved sequence motifs in the small subunit of human general transcription factor TFIIE</article-title>. <source>Nature</source><volume>354</volume>: <fpage>401</fpage>&#x02013;<lpage>404</lpage><pub-id pub-id-type="pmid">1956404</pub-id></citation></ref><ref id="b46"><citation citation-type="journal"><name><surname>Uesugi</surname><given-names>M</given-names></name>, <name><surname>Nyanguile</surname><given-names>O</given-names></name>, <name><surname>Lu</surname><given-names>H</given-names></name>, <name><surname>Levine</surname><given-names>AJ</given-names></name>, <name><surname>Verdine</surname><given-names>GL</given-names></name> (<year>1997</year>) <article-title>Induced alpha helix in the VP16 activation domain upon binding to a human TAF</article-title>. <source>Science</source><volume>277</volume>: <fpage>1310</fpage>&#x02013;<lpage>1313</lpage><pub-id pub-id-type="pmid">9271577</pub-id></citation></ref><ref id="b47"><citation citation-type="journal"><name><surname>Watanabe</surname><given-names>T</given-names></name>, <name><surname>Hayashi</surname><given-names>K</given-names></name>, <name><surname>Tanaka</surname><given-names>A</given-names></name>, <name><surname>Furumoto</surname><given-names>T</given-names></name>, <name><surname>Hanaoka</surname><given-names>F</given-names></name>, <name><surname>Ohkuma</surname><given-names>Y</given-names></name> (<year>2003</year>) <article-title>The carboxy terminus of the small subunit of TFIIE regulates the transition from transcription initiation to elongation by RNA polymerase II</article-title>. <source>Mol Cell Biol</source><volume>23</volume>: <fpage>2914</fpage>&#x02013;<lpage>2926</lpage><pub-id pub-id-type="pmid">12665589</pub-id></citation></ref><ref id="b48"><citation citation-type="journal"><name><surname>Xiao</surname><given-names>H</given-names></name>, <name><surname>Pearson</surname><given-names>A</given-names></name>, <name><surname>Coulombe</surname><given-names>B</given-names></name>, <name><surname>Truant</surname><given-names>R</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name>, <name><surname>Regier</surname><given-names>JL</given-names></name>, <name><surname>Triezenberg</surname><given-names>SJ</given-names></name>, <name><surname>Reinberg</surname><given-names>D</given-names></name>, <name><surname>Flores</surname><given-names>O</given-names></name>, <name><surname>Ingles</surname><given-names>CJ</given-names></name>, <name><surname>Greenblatt</surname><given-names>J</given-names></name> (<year>1994</year>) <article-title>Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53</article-title>. <source>Mol Cell Biol</source><volume>14</volume>: <fpage>7013</fpage>&#x02013;<lpage>7024</lpage><pub-id pub-id-type="pmid">7935417</pub-id></citation></ref><ref id="b49"><citation citation-type="journal"><name><surname>Yamamoto</surname><given-names>S</given-names></name>, <name><surname>Watanabe</surname><given-names>Y</given-names></name>, <name><surname>van der Spek</surname><given-names>PJ</given-names></name>, <name><surname>Watanabe</surname><given-names>T</given-names></name>, <name><surname>Fujimoto</surname><given-names>H</given-names></name>, <name><surname>Hanaoka</surname><given-names>F</given-names></name>, <name><surname>Ohkuma</surname><given-names>Y</given-names></name> (<year>2001</year>) <article-title>Studies of nematode TFIIE function reveal a link between Ser-5 phosphorylation of RNA polymerase II and the transition from transcription initiation to elongation</article-title>. <source>Mol Cell Biol</source><volume>21</volume>: <fpage>1</fpage>&#x02013;<lpage>15</lpage><pub-id pub-id-type="pmid">11113176</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="f1"><label>Figure 1</label><caption><p>The C-terminal acidic domain (AC-D) of hTFIIE&#x003b1;. (<bold>A</bold>) Sequence alignment of hTFIIE&#x003b1; AC-D and its homologues. H, human; M, mouse; X, <italic>Xenopus laevis</italic>; D, <italic>Drosophila melanogaster</italic>; C, <italic>Caenorhabditis elegans</italic>; Sp, <italic>Schizosaccharomyces pombe</italic>; Sc, <italic>Saccharomyces cerevisiae</italic>. Acidic amino acids, D and E are coloured in red. Conserved residues are shown in bold. The p62 PH-D-binding site of hTFIIE&#x003b1; and similar sequences are underlined. Secondary structures of hTFIIE&#x003b1; AC-D are depicted above human sequence. Arrows and cylinders represent &#x003b2;-strands and &#x003b1;-helices, respectively. Orange circles indicate residues participating in the formation of the hydrophobic core. Yellow circles indicate mutation sites. (<bold>B</bold>) Solution structure of hTFIIE&#x003b1; AC-D. Left, superposition of the backbone heavy atoms of the 20 lowest energy NMR structures. Right, ribbon representation of the average structure.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj200847f1"/></fig><fig id="f2"><label>Figure 2</label><caption><p>The pleckstrin homology domain (PH-D) of the p62 subunit of hTFIIH directly binds to hTFIIE&#x003b1; AC-D. (<bold>A</bold>) Schematic drawing of GST fusion hTFIIH p62 deletion mutants. (<bold>B</bold>) GST pull-down assay of hTFIIE&#x003b1; AC-D with wild type and p62 mutants. Lane 1, GST; lane 2, GST&#x02013;p62 (1&#x02013;548aa); lane 3, GST&#x02013;p62 (1&#x02013;108aa); lane 4, GST&#x02013;p62 (1&#x02013;238aa); lane 5, GST&#x02013;p62 (1&#x02013;333aa); lane 6, GST&#x02013;p62 (109&#x02013;548aa); lane 7, GST&#x02013;p62 (238&#x02013;548aa); lane 8, GST&#x02013;p62 (333&#x02013;548aa); lane 9, 20&#x00025; input. Arrowheads on the left side indicate band position of hTFIIE&#x003b1; AC-D and wild type (hTFIIE&#x003b1; wt) as indicated. Bound proteins were detected by western blotting with anti-hTFIIE&#x003b1; antisera (anti-IIE&#x003b1;) (lower panel). The p62 PH-D deletion mutants are indicated on the top of the panel.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj200847f2"/></fig><fig id="f3"><label>Figure 3</label><caption><p>Structure of complex of hTFIIE&#x003b1; AC-D and hTFIIH p62 PH-D. (<bold>A</bold>) Superposition of the backbone heavy atoms of the 20 lowest energy NMR structures. Structures are superimposed over residues 383&#x02013;433 of hTFIIE&#x003b1; AC-D shown in green, and residues 7&#x02013;104 of p62 PH-D shown in orange (left), residues 393&#x02013;433 of TFIIE&#x003b1; AC-D (middle) and residues 7&#x02013;104 of p62 PH-D (right), respectively. (<bold>B</bold>) Ribbon representation of the average structure. (<bold>C</bold>) Electrostatic interaction. Positive and negative potentials on the molecular surface are coloured in blue and red, respectively. (<bold>D</bold>) Binding pocket of p62 PH-D for F387 of hTFIIE&#x003b1; AC-D. (<bold>E</bold>) Binding pocket of p62 PH-D for V390 of hTFIIE&#x003b1; AC-D. In (C&#x02013;E), hTFIIE&#x003b1; AC-D is represented as a stick model, and p62 PH-D is shown as a molecular surface. (<bold>F</bold>) Interface between the core structure of hTFIIE&#x003b1; AC-D and p62 PH-D. Residues that participate in the binding are shown with the side chains.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj200847f3"/></fig><fig id="f4"><label>Figure 4</label><caption><p>Binding surfaces between hTFIIE&#x003b1; AC-D and p62 PH-D are essential for transcription and CTD phosphorylation. (<bold>A</bold>) SDS&#x02013;PAGE of the hTFIIE&#x003b1; mutants. In total, 400 ng of each purified hTFIIE&#x003b1; protein was subjected to SDS&#x02013;PAGE (10&#x00025; acrylamide) and stained with Coomassie blue. Lane 1, wild-type hTFIIE&#x003b1;; lanes 2&#x02013;12, point mutants. The sizes of the molecular weight markers are indicated on the right (in kDa). Mutated residues are indicated at the top of each lane. (<bold>B</bold>) Effect of point mutations of hTFIIE&#x003b1; on p62 PH-D binding. The top panel shows 5&#x00025; input of hTFIIE&#x003b1; mutant proteins (IIE&#x003b1; mutants). hTFIIE&#x003b1; proteins bound to the GST-tagged p62 PH-D and hTFIIE&#x003b2; were separated by SDS&#x02013;PAGE and detected by western blotting with anti-hTFIIE&#x003b1; antisera. Lane 1, no hTFIIE&#x003b1; (&#x02212;IIE&#x003b1;); lane 2, hTFIIE&#x003b1; wild type (IIE&#x003b1; wt); lanes 3&#x02013;13, point mutant proteins. Mutated residues are indicated at the top of each lane. (<bold>C</bold>) Effects of hTFIIE&#x003b1; AC-D point mutations on the basal transcription activity. Relative transcription activities (bars) of the mutant hTFIIE&#x003b1; proteins with a linearized template are presented by defining the transcription activity of wild-type hTFIIE&#x003b1; as 100&#x00025;. Mutated residues are indicated at the top of each panel. As a control, transcription was performed without hTFIIE&#x003b1; (&#x02212;IIE&#x003b1;). An arrow (right side of panel) indicates the position of the 390-nt transcripts. (<bold>D</bold>) Effects of hTFIIE&#x003b1; AC-D point mutations on hTFIIH-mediated CTD phosphorylation. The kinase assay was performed with Pol II, hTFIIH, hTFIIE&#x003b1; and hTFIIE&#x003b1; mutants in the absence of DNA. Lane 1, no hTFIIE&#x003b1; (&#x02212;IIE&#x003b1;); lane 2, wild-type hTFIIE&#x003b1; (IIE&#x003b1; wt); lanes 3&#x02013;13, point mutants. The mutated residues are indicated at the top of each lane. Arrows indicate the phosphorylated form (IIo) and the unphosphorylated form (IIa) of the largest subunit Rpb1 of Pol II.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj200847f4"/></fig><fig id="f5"><label>Figure 5</label><caption><p>hTFIIE&#x003b1; AC-D shares the p62 PH-D-binding surface with p53 TAD. (<bold>A</bold>) Structure of hTFIIE&#x003b1; AC-D&#x02013;hTFIIH p62 PH-D complex. (<bold>B</bold>) Structure of p53 TAD2&#x02013;Tfb1 PH-D complex (PDB ID; 2GS0). Interacting residues are indicated with the side chains and interaction areas are roughly marked in yellow. Residues that form the binding pockets for F387 of hTFIIE&#x003b1; AC-D and for F54 of p53 TAD2 are labelled. In (B), the residues of Tfb1 that are important in the interaction with F54 of p53 TAD2 are marked together with the corresponding residues of p62. (<bold>C</bold>) Effect of p62 PH-D point mutations on binding to the acidic region of hTFIIE&#x003b1; and p53. The top panel shows 5 ng of FLAG-tagged p62 PH-D mutant proteins (p62 PH-D mutants). p62 PH-D mutants were mixed with GST&#x02013;hTFIIE&#x003b1; wild type (IIE&#x003b1; wt), GST&#x02013;hTFIIE&#x003b1;<sub>351&#x02212;439</sub> (IIE&#x003b1;<sub>351&#x02212;439</sub>), GST&#x02013;hTFIIE&#x003b1; AC-D (IIE&#x003b1; AC-D) or GST&#x02013;p53<sub>1&#x02212;73</sub> (p53<sub>1&#x02212;73</sub>) bound to the glutathione-Sepharose resin. Bound mutants were subjected to SDS&#x02013;PAGE and detected by western blotting with anti-FLAG antibody. Lane 1, no p62 PH-D (&#x02212;p62 PH-D); lane 2, wild-type p62 PH-D (p62 PH-D wt); lanes 3&#x02013;9, p62 PH-D point mutants. Mutated residues are indicated at the top of each lane. (<bold>D</bold>) Competition of p53 TAD binding to p62 PH-D with hTFIIE&#x003b1;. FLAG-tagged p62 PH-D was mixed with GST&#x02013;p53<sub>1&#x02212;73</sub> (p53<sub>1&#x02212;73</sub>). For competition study, 6H&#x02013;hTFIIE&#x003b1; wild type was added to the mixture bound to glutathione-Sepharose (glut-Seph) resin. Unbound material was then added to Ni-NTA agarose. Bound proteins were subjected to SDS&#x02013;PAGE and detected by western blotting with anti-FLAG, anti-p53 and anti-hTFIIE&#x003b1; antisera.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj200847f5"/></fig><table-wrap id="t1" position="float"><label>Table 1</label><caption><p>Structural statistics for the 20 best structures of hTFIIE&#x003b1; AC-D and its complex with hTFIIH p62 PH-D</p></caption><table frame="hsides" rules="groups" border="1" width="85%"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">Free</th><th colspan="3" align="center" valign="top" charoff="50">Complex</th></tr><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">hTFIIE&#x003b1; AC-D</th><th align="center" valign="top" charoff="50">Htfiie&#x003b1; AC-D</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">hTFIIH p62 PH-D</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50"><italic>Experimental restraints</italic></td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Total distance restraints</td><td align="center" valign="top" charoff="50">1205</td><td align="center" valign="top" charoff="50">1296</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">2822</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Intraresidue</td><td align="center" valign="top" charoff="50">101</td><td align="center" valign="top" charoff="50">145</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">287</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Sequential (<italic>i</italic>&#x02013;<italic>j</italic>=1)</td><td align="center" valign="top" charoff="50">372</td><td align="center" valign="top" charoff="50">372</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">701</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Medium-range (1&#x0003c;<italic>i</italic>&#x02013;<italic>j</italic>&#x0003c;5)</td><td align="center" valign="top" charoff="50">367</td><td align="center" valign="top" charoff="50">391</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">536</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Intramolecular long range (<italic>i</italic>&#x02013;<italic>j</italic>&#x02a7e;5)</td><td align="center" valign="top" charoff="50">333</td><td align="center" valign="top" charoff="50">344</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">1222</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Intermolecular</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">371</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Hydrogen bond</td><td align="center" valign="top" charoff="50">16 &#x000d7; 2</td><td align="center" valign="top" charoff="50">22 &#x000d7; 2</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">38 &#x000d7; 2</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Number of dihedral restraints</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;&#x003d5;</td><td align="center" valign="top" charoff="50">35</td><td align="center" valign="top" charoff="50">35</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">65</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;&#x003a8;</td><td align="center" valign="top" charoff="50">32</td><td align="center" valign="top" charoff="50">35</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">64</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;&#x003c7;<sub>1</sub></td><td align="center" valign="top" charoff="50">21</td><td align="center" valign="top" charoff="50">25</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">46</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;&#x003c7;<sub>2</sub></td><td align="center" valign="top" charoff="50">1</td><td align="center" valign="top" charoff="50">2</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">10</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50"><italic>Statistics for structure calculations</italic></td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;r.m.s. deviations from experimental restraints<sup>a</sup></td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Distance (&#x000c5;)</td><td align="center" valign="top" charoff="50">0.010&#x000b1;0.000</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0.014&#x000b1;0.000</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Dihedral (deg)</td><td align="center" valign="top" charoff="50">0.080&#x000b1;0.026</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0.47&#x000b1;0.03</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;r.m.s. deviations from idealized covalent geometry</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Bonds (&#x000c5;)</td><td align="center" valign="top" charoff="50">0.0020&#x000b1;0.0001</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0.0020&#x000b1;0.0000</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Angles (deg)</td><td align="center" valign="top" charoff="50">0.53&#x000b1;0.00</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0.55&#x000b1;0.00</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Improper (deg)</td><td align="center" valign="top" charoff="50">0.40&#x000b1;0.01</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0.44&#x000b1;0.01</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Final energies</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;E total (kcal mol<sup>&#x02212;1</sup>)</td><td align="center" valign="top" charoff="50">100.5&#x000b1;0.6</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">347.8&#x000b1;4.2</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;E bond (kcal mol<sup>&#x02212;1</sup>)</td><td align="center" valign="top" charoff="50">3.3&#x000b1;0.3</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">11.1&#x000b1;0.4</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;E angle (kcal mol<sup>&#x02212;1</sup>)</td><td align="center" valign="top" charoff="50">75.3&#x000b1;0.6</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">230.4&#x000b1;1.9</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;E van der Waals (kcal mol<sup>&#x02212;1</sup>)</td><td align="center" valign="top" charoff="50">3.1&#x000b1;0.4</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">20.6&#x000b1;1.7</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;E NOE (kcal mol<sup>&#x02212;1</sup>)</td><td align="center" valign="top" charoff="50">6.5&#x000b1;0.5</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">41.5&#x000b1;2.8</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;E dihedral (kcal mol<sup>&#x02212;1</sup>)</td><td align="center" valign="top" charoff="50">0.0&#x000b1;0.0</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">3.6&#x000b1;0.5</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;E improper (kcal mol<sup>&#x02212;1</sup>)</td><td align="center" valign="top" charoff="50">12.4&#x000b1;0.6</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">40.6&#x000b1;1.1</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Coordinate precision</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Backbone atoms (&#x000c5;)</td><td align="center" valign="top" charoff="50">0.24&#x000b1;0.08<sup>b</sup></td><td align="center" valign="top" charoff="50">0.20&#x000b1;0.04<sup>b</sup></td><td align="center" valign="top" charoff="50">0.44&#x000b1;0.08<sup>c</sup></td><td align="center" valign="top" charoff="50">0.58&#x000b1;0.11<sup>d</sup></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Heavy atoms (&#x000c5;)</td><td align="center" valign="top" charoff="50">0.70&#x000b1;0.07<sup>b</sup></td><td align="center" valign="top" charoff="50">0.68&#x000b1;0.05<sup>b</sup></td><td align="center" valign="top" charoff="50">0.85&#x000b1;0.10<sup>c</sup></td><td align="center" valign="top" charoff="50">0.95&#x000b1;0.10<sup>d</sup></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ramachandran plot statistics</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Most favoured regions (&#x00025;)</td><td align="center" valign="top" charoff="50">82.9<sup>b</sup></td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">79.4<sup>d</sup></td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Additional allowed regions (&#x00025;)</td><td align="center" valign="top" charoff="50">17.1<sup>b</sup></td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">16.9<sup>d</sup></td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Generously allowed regions (&#x00025;)</td><td align="center" valign="top" charoff="50">0.0<sup>b</sup></td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">2.9<sup>d</sup></td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02003;Disallowed regions (&#x00025;)</td><td align="center" valign="top" charoff="50">0.0<sup>b</sup></td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0.7<sup>d</sup></td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td colspan="5" align="center" valign="top" charoff="50">None of the structures exhibited distance violations &#x0003e;0.5 &#x000c5;, dihedral angle violations &#x0003e;5&#x000b0;.</td></tr><tr><td colspan="5" align="center" valign="top" charoff="50">The value was calculated over residues 393&#x02013;433 of hTFIIE&#x003b1; AC-D of the free form or in the complex.</td></tr><tr><td colspan="5" align="center" valign="top" charoff="50">The value was calculated over residues 7&#x02013;104 of hTFIIH p62 PH-D in the complex.</td></tr><tr><td colspan="5" align="center" valign="top" charoff="50">The value was calculated over residues 383&#x02013;433 of hTFIIE&#x003b1; AC-D and residues 7&#x02013;104 of hTFIIH p62 PH-D in the complex.</td></tr></tbody></table><graphic alternate-form-of="t1" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj200847t1"/></table-wrap></floats-wrap></article> 